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SUMMARY OF THESIS:
Dictyostelium discoideum is a eukaryotic amoeba that has proven to be an excellent 
model system for the study of chemotaxis and development. Upon starvation, 
individual amoebae are able to aggregate and undergo development to form a fruiting 
body. Previously it has been demonstrated that this process is disrupted by two drugs 
commonly used to treat bipolar disorder, lithium and valproic acid (VPA), and that a 
ablation of the gene encoding prolyl oligopeptidase (PO) is able to confer resistance 
to this effect. Both drugs also have the common property of depleting intracellular 
inositol levels, and the observation that PO null cells have increased production 
inositol 1.4,5 trisphosphate (Ins( 1.4.5)P3) from the dephosphorylation of InsP5 
therefore suggests that this may be responsible for lithium resistance.
In this study I have cloned and generated mutants of the gene encoding this activity 
and shown that it is essential for lithium resistance in PO null cells and that this 
resistance is due to upregulated transcription of the lithium-sensitive IMPase family 
of genes. In addition I have shown that cells lacking phospholipase C activity are also 
lithium resistant, indicating that the recycling of inositol phosphates and lipids plays 
an important role in maintaining cell movement and lithium action.
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Abstract
Dictyostelium discoideum  is a eukaryotic amoeba that has proven to be an excellent 
model system for the study of chemotaxis and development. Upon starvation, individual 
amoebae are able to aggregate and undergo development to form a fruiting body. 
Previously it has been demonstrated that this process is disrupted by two drugs 
commonly used to treat bipolar disorder, lithium and valproic acid (VPA) and in this 
study I show that this disruption is due to the inhibition of cell movement. Previous work 
has shown that ablation of the gene encoding prolyl oligopeptidase (PO) is able to confer 
resistance this effect.
Both drugs have the common property of depleting intracellular inositol levels, and the 
observation that PO null cells have increased production of inositol 1,4,5 trisphosphate 
(Ins( 1,4,5)P3) from the dephosphorylation of InsP5 therefore suggests that this activity 
may be responsible for lithium resistance. In this study I have cloned, and generated 
mutants of, the gene encoding this inositol phosphatase activity and shown that it is 
essential for lithium resistance in PO null cells and that this resistance is due to 
upregulated transcription of the lithium-sensitive IMPase family of genes. In addition I 
have shown that cells lacking phospholipase C activity are also lithium resistant, 
indicating that the recycling of inositol phosphates and lipids plays an important role in 
maintaining cell movement and lithium action.
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Chapter 1: 
Introduction
1.1 Dictyostelium  and lithium
The effects of lithium on Dictyostelium  development were originally studied in 1970 
by Maeda (Maeda, 1970) and it was observed that when cells are starved and allowed 
to undergo development in the presence of lithium, two effects are seen. Treatment 
with 7mM LiCl affects differentiation, causing the fruiting body to suffer from a mis- 
proportioning of cell types where the spore head virtually disappears and the basal 
disc is enlarged (Maeda, 1970; Peters et al.. 1991). This is likely to be due to 
inhibition of glycogen synthase kinase a (GskA, the Dictyostelium  homologue of 
GSK3) as it is reminiscent of the phenotype seen upon inactivation of this gene 
(Harwood et ah, 1995). In addition, when cells develop at concentrations of lithium 
chloride above lOmM. aggregation is blocked (an effect also seen in the presence of 
ImM valproic acid). As cells lacking any GskA activity are still able to aggregate, 
albeit with morphological defects, this suggests that other targets of lithium are 
responsible (see fig 1.1) (Harwood et ah, 1995).
Biochemically, lithium treatment of Dictyostelium has also been shown to disrupt 
phosphoinositol metabolism, and is able to decrease both the basal as well as the 
receptor stimulated levels of Ins(l,4,5)P3 (Peters et ah, 1991) as well as affecting the 
activation of G-proteins, and the production of cyclic GMP (Peters et ah, 1992). 
Indeed, depletion of inositol is a common property of both lithium and another mood- 
stabilising drug, valproic acid (VPA) which is also able to deplete intracellular 
lns( 1.4.5)P_?, and therefore
2
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Figure 1.1: The effects of lithium on Dictyostelium development. (A) the
Dictyostlelium developmental cycle, where single cells aggregate together to form 
multicellular bodies, finally resulting in a fruiting body. (B-D) Wild-type 
Dictyostelium allowed to develop on non-nutrient agar in (B) lOmM NaCl, (C) lOmM 
LiCl and (D) 7mM LiCl. (E) shows the developmental phenotype of gskA null cells, 
no lithium. Images taken from (Harwood et al., 1995; Williams et al., 1999)
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inhibition of inositol signaling may represent a conserved therapeutic activity 
(Williams et al.. 2002). The aim of this study is therefore to determine the mechanism 
by which lithium is able to block Dictyostelium aggregation and understand the role 
of inositol signaling in both lithium treatment and cell movement in general.
1.2 The Dictyostelium model system
Dictyostelium are eukaryotic social amoebae, which modern phylogenic trees place as 
having diverged from the other metazoa after the animals and plants split (Baldauf 
and Doolittle, 1997; Eichinger et al.. 2005). Dictyostelium  has a complex life cycle 
and is able to undergo chemotaxis. development and differentiation and has a large 
number of functions in common w ith animal as well as well as plants and fungal cells, 
l or example. Dictyostelium  is the only lower eukaryote to possess class I 
phosphatidyl inositol 3'kinases. and outside of the animal kingdom, Dictyostelium is 
the only species which has been shown to have SI 12 domain, phosphotyrosine 
signaling, although no receptor tyrosine kinases could be found (Eichinger et al., 
2005). These properties, combined w ith ease of genetic manipulation and culture 
make Dictyostelium is an excellent and appropriate system for the study of many 
biological processes.
Dictyostelium cells have a complex life cycle, consisting of single-cell vegetative and 
multicellular developmental phases. In this system, when bacterial or liquid nutrients 
are plentiful, the cells grow as independent amoebae and move randomly with 
amoeboid movement. However, when the food source is in short supply, the cells
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initiate a developmental process, and quickly alter the expression of many genes. Two 
such genes are adenylyl cyclase, which leads to the formation of waves of secreted 
cyclic adenosine monophosphate (cAMP), as well as its receptor cARl (Rathi and 
Clarke. 1992; Schulkes and Schaap. 1995). In response to the cAMP gradient formed, 
cells rapidly move towards the source, chemotaxing towards the signal, to form 
aggregates of up to 200.000 cells. At this stage, the amoebae start to differentiate into 
different cell types and form a defined multicellular slug, which is able to more along 
the substratum. Finally a decision is made and the morphology changes again to form 
a mature fruiting body consisting of a spore head held aloft by a stalk. This fruiting 
body contains spore cells that germinate when dispersed in the hope of finding more 
food. This process is summarized in figure 1.1. This lifecycle, which takes 
approximately 24 hours to complete, represents a robust system for both chemotaxis 
and development. Along with relatively easy genetic manipulation this makes 
Dictyostelium an excellent model organism for the study of these processes.
The Dictyostelium genome is relatively gene-rich, with approximately 12,500 genes 
encoded in just 34 megabases of DNA. This is split into 6 chromosomes and although 
it is possible to select and grow diploid cells, cultures are generally haploid. With the 
recent completion of the genome sequence, this therefore allows for fairly 
straightforward genetic manipulations such as the generation of null mutants, and the 
ability to generate large numbers of mutants to carry out genetic screens (Kuspa and 
Loomis. 1992).
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1.3 Chemotaxis in Dictyostelium
Upon lithium treatment. Dictyostelium  aggregation is disrupted. Although the 
mechanism of this is not understood, it must involve either disruption of 
developmental or chemotactic signal transduction, or the ability to act upon it and 
move efficiently towards each other. By studying the chemotactic behaviour of cells 
treated with lithium as well as the properties of lithium resistant mutants is should be 
possible to clarity this and understand more about the processes involved in cell 
migration.
The process of chemotaxis has been extensively studied in Dictyostelium. As also 
seen in neutrophils, cells respond to a gradient of chemoattractant by the induction of 
actin polymerization at the leading edge of the cell, along with myosin contraction at 
the rear. Cells are exceptionally sensitive to even very shallow gradients, being able to 
respond to just a 2% difference in chemoattractant concentration between the front 
and the back of the cell (Mato et al., 1975). In the absence of a gradient, cells move 
around randomly producing new pseudopodia in every direction, but when a 
chemoattractant gradient is introduced, this is biased such that the cell preferentially 
produces and maintains pseudopodia towards the source, whilst suppressing them 
elsewhere. This polarizes cell morphology towards the cAMP source, although the 
cAMP receptors remain uniforml)' distributed at all times (Funamoto et al.. 2002).
This polarity can however be transient as, if the chemotactic source is moved the cell 
is able to ov ercome this lateral pseudopod repression, and re-orientate itself by the 
production of a new leading edge, (Chen et al., 2003; Swanson and Taylor, 1982). 
Although this method of cell turning does happen in the presence of steep gradient of
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cAMP, Dictyostelium  cells will also frequently do a U-turn, retaining the same 
primary pseudopod. This is the preferred mechanism of turning in neutrophils 
(Zigmond. 1977), and the degree to which a cell will make a new pseudopod rather 
than turn may even be actively regulated as Dictyostelium cells become more strongly 
polar as they progress through development.
It is in the formation and maintenance of this polarity that inositol phospholipids have 
been strongly implicated. In response to activation of the cAMP receptor, the class I 
PI-3' kinases are rapidly activated, producing a patch of PtIns(3,4,5)P3 at the plasma 
membrane (Stephens et al., 1993). This occurs in a spatially regulated manner, with 
PtIns(3,4.5)P3 tightly localised at the leading edge of the cell, in the direction of the 
chemoattractant source. In addition, the 5’ phosphatase PTEN forms a reciprocal 
pattern, repressing PtIns(3,4,5)P3 accumulation everywhere else (Funamoto et al.,
2002). This can be visualised using a specific PtIns(3,4,5)P3-binding plecstrin 
homology (PH)-domain probe fused with GFP, and has been used to show 
PtIns(3,4,5)P3 production in areas of actin polymerization in neutrophils, 
Dictyostelium , and fibroblasts (Haugh et al., 2000; Parent et al., 1998; Servant et al.,
2000 ).
Using this ability to bind PH-domain containing proteins, PtIns(3,4,5)P3 is able to 
recruit proteins, including the cytosolic regulator of adenylyl cyclase (CRAC), 
Akt/PKB and PhdA specifically to the leading edge of the cell, coinciding with actin 
polymerization and pseudopod formation (Funamoto et al., 2001; Meili et al., 1999; 
Parent et al., 1998; Servant et al., 2000). Indeed, Dictyostelium  cells contain six
7
potential class I PI3’ kinases and although there is some degree of functional 
redundancy, a PI3K1/2 double mutant has a severe loss of cell polarity, producing 
multiple pseudopodia along the periphery of the cell (Chung et al., 2001; Funamoto et 
al.. 2001). There are two groups of proteins able to negatively regulate the level of 
PtIns(3,4,5)P3; these are the 3’ phosphatase PTEN which reverses the action of PI3K, 
and a family of inositol 5’phosphatases that produce PtIns(3,4)P2. Although 
inactivation of the 5 'phosphatases does not appear to affect movement (Loovers et al.,
2003), disruption of the single PTEN gene results in a reduction in both polarity and 
chemotaxis efficiency (Funamoto et al., 2002; Iijima and Devreotes, 2002) and this 
has lead to the proposal that localized PtIns(3,4,5)P3 production plays a major 
instructive role in cell migration by biasing the direction of movement towards a 
chemoattractive source (Funamoto et al., 2002; Funamoto et al., 2001; Insall and 
Weiner, 2001; Niggli and Keller, 1997; Postma et al., 2004; Wennstrom et al., 1994). 
Recently however, a further study using a combination o fpi3k  null cells and a PI3K 
inhibitor, has shown that although the severe inhibition of cAMP-mediated 
PtIns(3.4.5)P3 production leads to inhibition of cAMP relay (presumably via CRAC), 
cell elongation and aggregation, cells are still able to orientate towards the 
chemoattractant source (Loovers et al., 2006). Therefore it may be that PtIns(3,4,5)P3 
production may simply provide a directed extra motile force, rather than being 
responsible for determining the orientation.
Although in most cells PtIns(4,5)P2 levels are much higher than PtIns(3,4,5)P3 and 
therefore do not undergo any change large enough to be a direct signal and specific 
PtIns(4,5)P2 binding PH domains fused to GFP indicate a uniform distribution along 
the plasma membrane, it has been proposed that it may still play an important,
permissive role in cell movement. In order for a cell to move its membrane forwards, 
it must activate actin polymerization and the formation of actin filaments. This is a 
highly regulated process and PtIns(4,5)P2 has been shown to interact with a number of 
proteins involved in the control of actin dynamics, including, profilin, filament- 
capping proteins and the Wiscott-Aldrich syndrome protein N-WASP (Higgs and 
Pollard, 2000; Hilpela et al., 2004; Miki et al., 1996; Ostrander et al., 1995; Palmgren 
et al.. 2001). Therefore, although the concentration and dynamics of PtIns(4,5)P2 do 
not appear to be sufficient for direct signaling, as it is tightly localised to the plasma 
membrane it may play an important, but more instructive role by directing the 
machinery required for actin polymerization to the cell periphery (Insall and Weiner,
2 0 0 1 ) .
1.4 Ins(l,4,5)P3 and Calcium signaling in chemotaxis
In addition to the activation of class I PI3’kinases, chemoattractant stimulation of 
cells also results in an increase in phospholipase C (PLC) activity, leading to the 
transient accumulation of Ins(l ,4,5)P3 and diacyglycerol (DAG) due to the hydrolysis 
ofPtIns(4.5)P2. This increased Ins(l,4.5)P3 is then capable of binding to its receptor 
on the surface of intracellular calcium stores and the plasma membrane, leading to 
both calcium influx and release from intracellular stores (Bumann et al., 1984; 
Schlatterer et al., 2004; Yumura et al., 1996). This results in a rapid increase in 
intracellular calcium levels, and the activation of numerous calcium-dependant 
proteins, some of which have been demonstrated to induce actin polymerization, 
including protein kinase C (Kishimoto et al., 1980).
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However, although this calcium response is common to many cell types, there is 
evidence to suggest that it is not important for chemotaxis. For example, the 
Dictyostelium genome contains a single PLC (a delta class) which, upon cAMP 
stimulation is activated by a G-protein dependant pathway, producing a transient rise 
in Ins(1.4,5)P3 (Bominaar et al., 1994; Europe-Finner et al., 1989; Okaichi et al., 
1992). Upon inactivation of this gene, all PLC activity is lost and yet the cells are still 
able to grow, chemotax and develop normally (Drayer et al., 1994). In fact so far, the 
only defect to be found in this mutant is the ability to control spore germination and 
levels ofIns(1.4,5)P3 are maintained due to a compensatory up-regulation of InsP.s 
hydrolysis (Van Dijken et al., 1997; Van Dijken and Van Haastert, 2001).
Other studies have also questioned the role of this signaling pathway in chemotaxis, 
as disruption of the single Dictyostelium  Ins(l,4,5)P3 receptor-like gene iplA results in 
cells in which calcium influx is abolished, yet again the cells can chemotax with a 
similar efficiency to wild-type (Traynor et al., 2000). This is in agreement with some 
previous studies where the addition of calcium chelators did not affect neutrophil 
chemotaxis (Marasco et al., 1980; Maxfield, 1993), although there is also evidence 
that iplA' cells can still undergo some calcium influx, through a capacitance-driven 
entry that is unaffected by this mutation. This, and other studies have also shown that 
chemotaxis is severely disrupted by the presence of calcium chelators in the 
cytoplasm (Schlatterer and Malchow, 1993; Unterweger and Schlatterer, 1995; Van 
Duijn and Van Haastert, 1992), although this may well be due to lowered basal 
calcium levels disrupting the cell in a more general sense, and not a direct result on 
Ins(l,4,5)P3 signaling. If calcium signaling does not prove to be important for 
chemotaxis it is an interesting question why the cell the cell initiates PLC activation
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and produces Ins(l,4,5)P3 so sharply in response to stimulation. There is some 
evidence that Ins(l,4,5)P3 may be able to regulate developmental gene expression and 
therefore, although why it should be activated in a cyclical nature is unclear, 
alternative more subtle roles may exist (Ginsburg and Kimmel, 1989; Kimmel and 
Eisen. 1988).
One of the problems in the study of the pathways described above is the degree of 
functional redundancy in this system, indicating the fundamental importance of cell 
movement in survival. From many of these studies, it is clear that in when cells are 
aggregating efficiently, a number of processes are involved and often the loss of one 
may be compensated by the up-regulation of others. Both lithium and VPA however, 
are able to completely block aggregation as well as deplete Ins(l,4,5)P3 levels 
(Williams et al.. 2002) and therefore by the study of this mechanism we hope to gain 
further insight into this process.
1.5 Lithium and bipolar disorder
Both lithium and VPA are widely used as mood stabilizers for the treatment of bipolar 
affective disorder (BAD), previously known as manic depression. Although they have 
both been used for many years and are effective, the therapeutic mechanism of their 
action as well as the underlying cause of the condition remain unclear. Bipolar 
disorder is a mood disorder that affects up to 1% of the population and although the 
condition is alleviated in most treated patients, both drugs have unpleasant side effects 
and are teratogenic and some patients fail to respond (Lenox et al., 1998; 2003).
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The main difficulty facing the development of new treatments is that neither the 
condition, nor the action of the drugs is clearly understood. One approach to resolve 
this is to look for common signaling /metabolic pathways affected by different drugs. 
To date, three classes of proteins have been shown to be directly inhibited by lithium 
at therapeutic doses (about 0.5-1.5mM for lithium, and 0.5mM for valproic acid) 
(Manji et al.. 1995). These are the glycogen synthase kinase-3 (GSK3) family of 
serine/threonine protein kinases, regulating numerous cellular events including 
glycogen metabolism and wnt signaling (1996); a family of phosphomonoesterases, 
typified by inositol monophosphatase (IMPase) and 3’(2’)-phosphoadenosine (PAP) 
phosphatase (1995; Murguia et al., 1995; 1994; York et al., 1995); and the enzyme 
phosphoglucomutase, involved in glucose metabolism (Ray et al., 1978).
Valproic acid has also been shown to affect both wnt signaling (although by an 
indirect, undetermined mechanism), and inositol synthesis (2002; O'Donnell et al., 
2003; Williams et al., 2002; Williams et al., 1999; 2001). In addition, at therapeutic 
lev els (K, =0.4mM) it is also an inhibitor of histone deacetylase activity and therefore 
may affect transcriptional regulation and explain its teratogenicity (Phiel et al., 2001).
Specificity is therefore a problem with both drugs, both leading to unpleasant side- 
effects and complicating the study of their therapeutic action. However hitting 
multiple targets may also actually be critical for the drugs to work, and therefore in 
order to try and generate better, alternative treatments, we must endeavour to 
understand the relative contribution of each. In Dictyostelium both lithium and VPA 
have the common action of blocking aggregation and therefore in understanding both
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the relevant targets and the mechanism by which this happens we also learn more 
about the therapeutic affects of these drugs in the brain.
1.6 The known molecular targets of lithium
1.6.1 Inhibition of glycogen synthase kinase
GSK3 is a multifunctional protein kinase found in all eukaryotes. It was first 
identified as a kinase that phosphorylates and inactivates glycogen synthase (Frame 
and Cohen, 2001), a central enzyme in the insulin response but has since been 
discovered to mediate a number of other pathways (Doble and Woodgett, 2003). The 
most well known of these is the canonical wnt signaling pathway, whereby 
phosphorylation of p-catenin by GSK3 leads to its degradation. In response to wnt 
binding to the Frizzled or LRP5/6 cell surface receptors this phosphorylation is 
inhibited and P-catenin accumulates in the nucleus, leading to transcriptional 
activation.
In Dictyostelium  it has been shown that lithium can directly inhibit GskA (the 
Dictyostelium  homologue) with a K, of 2 mM (2001). As wnt signaling is highly 
active during development it would seem probable that GskA inhibition can explain 
the teratogenic effects observed with lithium treatment. Indeed, when Dictyostelium  
cells lacking GskA activity undergo development, cell-type specification goes awry, 
leading to increased numbers of stalk cells and a decrease in spores as has also been 
observed at low concentrations of lithium (Harwood et al., 1995; Peters et al., 1989).
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Although it is unlikely that GskA inhibition is responsible for inhibition of 
Dictyostelium aggregation, it should not be disregarded merely as a mechanism for 
the teratogenic side effects of lithium and a number of its substrates have the potential 
to be involved in neuronal function. Neurogenesis, and therefore neuronal 
development has recently been reported in the adult brain of several species (Alvarez- 
Buylla et al., 2001; Gould and Gross, 2002; Gould et al., 1999; Sanai et al., 2004) and 
GSK.-3 has also been implicated in the regulation of neuronal apoptosis (Longo et al.. 
2002; Takashima et al., 1996; Takashima et al., 1993). In addition, lithium and wnt 
signaling have been shown to modulate axonal structure, modulating microtubule 
stabilization and branching (Lucas et al., 1998; Lucas and Salinas, 1997) and other 
studies have also shown effects of VPA on Wnt signaling, maintaining the possibility 
that GSK3 could be a therapeutic target (2002; 2001).
1.6.2 Inhibition of IMPase and inositol depletion
An alternative theory for the mood-stabilizing properties of lithium and VPA is by 
interference with inositol metabolism. The six carbon sugar inositol forms many 
different phospholipid and soluble polyphosphates within the cell, many of which 
play important and diverse roles in signaling and movement, some of which have 
already been described.
As previous!) mentioned, lithium is a non-competitive inhibitor of the IMPase family, 
binding the enzyme-substrate complex with a K, of -LOmM dependant on species 
(Gee et al.. 1988). In many cell types this has been shown to reduce the levels of myo­
inositol and other inositol phosphates leading to the suggestion in 1989 by Berridge
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and colleagues that a mechanism of lithium action was to deplete inositol 
phospholipids and therefore suppress inositol-based signaling in the brain (1989). In 
addition. VPA has recently been shown to inhibit inositol synthase, the enzyme 
involved in the de novo synthesis of inositol from glucose-6-phosphate, and both 
drugs have the common ability to reduce the levels inositides, including Ins(l,4,5)P3 
in both rat brains and Dictyostelium  (O'Donnell et al., 2003; Shaltiel et al., 2004; 
Williams et al., 2002; Williams et al.. 1999).
Studies using sensory neuronal growth cones also implicate inositol depletion as a 
possible therapeutic mechanism. Normal migrating growth cones cycle between 
phases of rapid extension, with contracted ends, and stationary phases when the cones 
are spread. In this system, using cells from rat dorsal root ganglia (DRG’s), lithium, 
VPA and carbemazepine (an anti-epileptic drug with mood-stabilizing properties) all 
inhibit cell migration, as shown by increased spreading - an effect which was 
reversible by the addition of exogenous myoinositol (Lucas et al., 1998; Williams et 
al., 2002). In addition, a recent study has also found some evidence for a bipolar- 
linked polymorphism in the promoter of the IMPase 2 gene (Sjoholt et al., 2000), 
although a mouse knockout of this gene has no obvious behavioral phenotype (Cryns 
et al.. 2006).
In other model organisms, result have also been confusing, in yeast lithium is 
inhibitor) to growth, but disruption of both IMPase genes gave neither inositol 
auxotrophy nor any growth problems, indicating that a different mechanism is 
important for this effect. In addition, the same study also show that although IMPase 
overexpressing yeast are resistant to lithium, this is due to increased ion-channel
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activity and therefore lithium not accumulating within the cell (Lopez et al., 1999). 
This study was however merely looking at cell growth and used concentrations of 
lithium far in excess of those used therapeutically (up to lOOmM). In the brain, the 
actions of lithium and VPA are likely to be much more subtle, involving mechanisms 
that simply do not exist in yeast, such as chemotaxis. Indeed, in Drosophila 
melunogaster mutants lacking all IPP activity, a defect in synaptic transmission is 
seen. This is due to increased vesicle release at neuromuscular junctions -  an effect 
which is phenocopied by the lithium treatment of wild-type synapses (Acharya et al.. 
1998).
Although some of this evidence may prove to be misleading, there are nevertheless 
many lines of evidence that point towards a role for inositides in lithium action. 
Indeed, it may well be more than coincidence that all three known direct targets of 
lithium are involved in sugar metabolism and therefore may work co-ordinately along 
the same pathway to inhibit inositol production within the cell. Were this the case it 
would certainly make lithium an excellent drug, and may explain the difficulties in 
discovering more effective treatments. It therefore seems likely that inositol 
metabolism and signaling plays some role in the treatment, and potentially the cause, 
of bipolar disorder, and that the inositol-depletion effects of lithium and VPA are 
responsible for the inhibition of Dictyostelium  aggregation.
1.6.3 Inhibition of PAP-phosphatase
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3,(2’)-phosphoadenosine 5’phosphate (PAP) phosphatase is a member o f the same 
family of enzymes that includes IMPase and therefore is also inhibited by lithium. As 
the name suggests, the enzyme hydrolyses PAP to form adenosine 5’monophosphate 
(AMP) and is inhibited non-competitively by lithium with a Kj o f 0.3mM (Agam and 
Shaltiel, 2003; Yenush et al., 2000). Although not extensively studied, loss of the 
enzyme in yeast leads to PAP accumulation along with RNA processing and 
stabilization defects, and therefore may explain some of the transcriptional changes 
seen in mice after chronic lithium treatment (Dichtl et al., 1997). However, whether 
this is a therapeutic target remains unclear and as PAP phosphatase and IMPase have 
some cross-reactivity to each others substrate (Lopez-Coronado et al., 1999), PAP and 
inositol metabolism should not be seen as completely independent systems.
1.6.4 Inhibition of phosphoglucomutase
The enzyme phosphoglucomutase (PGM) is important for the metabolism of 
galactose, and regulates its entry into glycolysis. When galactose is metabolized, it is 
first converted into glucose-1-phosphate, which is then isomerised by PGM into 
glucose-6-phosphate before entering the glycolytic pathway. Interestingly, this is also 
the substrate o f inositol synthase, which converts glucose-6-phosphate into inositol-3- 
monophosphate. The K, for lithium of human PGM is 1.5mM and therefore is also 
likely to be inhibited at therapeutic levels and injection of lithium into brain tissue 
results in changed glucose phosphate levels. Therefore this effect may also play a 
significant role in lithium action (Csutora et al., 2005a; Csutora et al., 2005b; 
Nordenberg et al., 1982; Ray et al., 1978).
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1.7 Prolyl oligopeptidase and lithium resistance
In order to determine the mechanism and targets of the lithium treatment on 
aggregation, previous workers in this laboratory isolated a number of mutants 
resistant to this effect. As a model organism, Dictyostelium is fortunate enough to 
have a haploid genome; therefore it is possible to make a library of random insertional 
mutants and screen them for sensitivity to lithium (Kuspa and Loomis, 1992). In this 
screen, a mutant library was generated and grown clonally on a lawn of bacteria in the 
presence of lOmM lithium. As each clone grows and clears a plaque in the bacterial 
law n, the cells in the centre run out of food and initiate development. Mutants w'ere 
therefore screened for the ability to form fruiting-body structures under these 
conditions, where wild-type cells cannot.
The first of these mutants (lisA, for lithium suppressor A) was identified as a 
disruption o f the gene encoding prolyl oligopeptidase (PO) and is also cross-resistant 
to VPA (Williams et al.. 1999). In this mutant, cells will aggregate in up to 12mM 
LiCl. although they still exhibit the patterning defect attributed to GSKa inhibition. 
This therefore indicates that the two effects of lithium on Dictyostelium  development 
are distinct and that the two pathways can be resolved. Interestingly, when inositol 
levels are examined in this mutant, increased basal levels of Ins(l,4,5)P_3 are observed 
due to increased breakdown of more phosphorylated species. This observation has 
also been seen by others in astroglioma cells (Schulz et al., 2002) and therefore would 
point towards a mechanism whereby an elevated basal levels of inositides can protect 
against the inositol depleting effects of lithium and VPA.
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Prolyl oligopeptidase is a serine protease with the enzymatic activity of cleaving 
peptides on the carboxyl side of a proline residue and is not directly inhibited by 
either lithium or VPA (Williams et al., 1999). Although its cellular function and 
biological substrates are unclear, the crystal structure predicts an eight-bladed [3- 
propeller fold that would restrict entry into the active site to substrates smaller than 30 
amino acids (Hiramatsu et al., 2003; Rasmussen et al., 2003). The mammalian 
enzyme has been shown to be able to cleave a number of peptide hormones and 
neuropeptides (Polgar, 2002) although the majority of the enzyme activity appears to 
be intracellular, and therefore the biological relevance of these as substrates is 
uncertain. Tantalizingly however, reduced PO activity has also been associated with 
bipolar patients, as well as the neuronal damage in patients suffering from 
Alzheimer’s disease and cognitive enhancement in rats (Breen et al., 2004; Laitinen et 
al., 2001; Yoshimoto et al., 1987) and therefore it seems feasible that PO plays some 
role in brain function. Whether this is due to the regulation of inositol metabolism is 
unclear, although studies have reported reduced inositol levels in bipolar patients 
(Davanzo et al.. 2001; Shimon et al., 1997). An aim of this project is to investigate the 
mechanism of lithium resistance in PO null Dictyostelium and determine the 
contribution of inositol metabolism to this.
1.8 Signalling through inositol polyphosphates
Inositol is a <ix-carbon sugar molecule which, due to the ability o f each carbon to be 
independantly phosphorylated, can be converted into multiple forms, many of which 
have been assigned specific biological functions (see Fig. 1.2 for structure and 
annotation). In addition to single phophorylations, some positions can also be
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pyrophosphorylated (PP) so that in cells inositides have been found containing up to 8 
phosphate groups (Albert et al., 1997; Laussmann et al., 1996).
The ability of a single molecule to have so many phosphorylation states as well as 
multiple isomers within each state provides a powerful mechanism by which many 
functions can co-ordinately be regulated within the cell. So far these functions range 
from the stimulation of calcium release (Ins(l,4,5)P3), regulation of chloride ion 
channels (Ins(3,4,5,6)P4) (Carew et al., 2000; Ho et al., 2002), control of mRNA 
export from the nucleus (InsP6) (Miller et al., 2004; York et al., 1999), chromatin 
remodeling (InsP’s 4-6) (Shen et al., 2003; Steger et al., 2003) and even direct protein 
phosphorylation (pyrophosphates) (Saiardi et al., 2004) although there are doubtless 
others. Indeed, phvtate (inositol hexakisphosphate, InsPe) makes up almost two-thirds 
of the phosphate content of plant seeds, and its synthesis is essential for yolk sac 
development in mice, therefore is likely to also be used as an energy, or phosphate 
store (Stevenson-Paulik et al.. 2005; Verbsky et al., 2005a).
In addition to the more than 30 known soluble forms, inositol can also be joined to a 
lipid moiety to form phosphatidyl inositides. These can also be phosphorylated 
multiple times, and at present 7 forms are known. These again have numerous 
biological functions such as the regulation of endosomal trafficking, protein kinase B 
and protein kinase Ce regulation and the recruitment of proteins to specific sections of 
membrane \ ia pleckstrin homology (PH) domains as will be discussed later (Alessi 
and Cohen, 1998; Bos, 1995; Comer et al., 2005; Ikonomov et al., 2003; Sbrissa et al., 
2002; Stokoe et al., 1997).
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Figure 1.2: The structure o f inositol phosphates and phospholipids. The standard numbering 
system for each carbon is indicated in A and B and the structure o f phosphatidyl inositol lipids 
shown in C.
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This astonishing range of cellular functions and shear number of isoforms of inositol 
polyphosphates must therefore be tightly controlled by a number o f enzymes, many of 
which catalyse multiple steps. Over the last decade or so, many of these have been 
cloned and characterised and although many gaps and inconsistencies remain, a 
reasonable understanding o f this signalling network can be achieved and is discussed 
below (Abel et al.. 2001).
1.9 Inositol metabolic pathways
1.9.1 Ins(l,4,5)P3 signalling and attenuation
As mentioned above, there are many different inositol phosphates present in any cell 
and generally speaking any one species can be converted into any other via various 
intermediate steps (summarized in Fig. 1.3). The most well-understood pathway is 
undoubtably the production and subsequent recycling of Ins(l,4,5)P3 from 
PtIns(4,5)P2. In response to extracellular stimuli, phospholipase C (PLC) is activated 
via G-protein coupled receptors, causing PtIns(4,5)P2 hydrolysis and the production 
the second messengers diacyl glycerol (DAG) and Ins(l,4,5)P3. DAG then activates 
protein kinase C whereas Ins(l,4,5)P3 diffuses into the cytosol initiating Ca2+ release 
from intracellular stores, leading to a whole range of cellular responses (see later).
In order to terminate the signal, two different mechanisms are employed; first, 
Ins(l,4,5)P3 can be hydrolysed by 5’ and 1’ phosphatases to form Ins(4)P which is 
then subsequently converted into wyo-inositol by IMPase (inhibited by lithium), and
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recycled back to phosphatidyl inositol (Ptlns) (Abel et al., 2001; Van der Kaay et al., 
1995; van Haastert and van Dijken, 1997). Second, in Dictyostelium, yeast, 
Drosophila and plants the Ins(l,4,5)P3 signal can be attenuated by phosphorylation 
where a promiscuous inositol polyphosphate multikinase (IPMK) phosphorylates 
Ins(l,4,5)P3 on the 6' and/or 3' positions to produce In s(l,3,4,5,6)Ps (Odom et al., 
2000; Saiardi et al., 1999; Stevenson-Paulik et al., 2002). Mammalian cells (and 
particularly neurons) also have an adaptation where a specific calcium-activated 
Ins(l,4.5)P.3 3 'kinase (a specialized IPMK) rapidly forms Ins(1.3,4,5)P4 to attenuate 
the signal - although Ins(1.3,4,5)P4 has also been proposed to have its own signaling 
roles (Communi et al., 1995; Irvine et al., 1999; Schell et al.. 2001).
1.9.2 The formation of InsP6
As mentioned above, Ins(l,4,5)P3 can be sequentially phosphorylated to form higher 
order species; these can all eventually be converted to phytate, or InsP6. Again the 
pathways of IP6 synthesis vary slightly between organisms, but in all cases, the final 
step seems to be the phosphorylation of Ins(l,3,4,5,6)P5 at the 2' position. This is 
done by a specific 2'kinase, disruption of which blocks InsP6 production in plants, 
yeast, and mice (Miller et al.. 2004; Stevenson-Paulik et al., 2005; Verbsky et al., 
2005a; Verbsky et al., 2005b; Verbsky et al., 2002). Once made. InsP6 can then be 
pyrophosphorylated to form InsP7 and InsPs, or in Dictyostelium it is involved in 
futile cycles of interconversion to Ins(l,2,3,4,6)P5 and Ins(l ,2,4,5,6)P? with no 
apparent signaling purpose (Huang et al., 1998; Saiardi et al., 2001; Stephens and 
Irvine, 1990).
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In mammals, yeast and Drosophila, InsP6 is only formed from Ins(l,4,5)P3 and this 
activity is predominantly nuclear. In mammals, this is done via a dephosphorylation 
of Ins( 1,3.4.5)P3 to give Ins(l,3,4)P3 which is then sequentially phosphorylated at the 
6' and 5" positions by an Ins(l,3.4)P3 5/6’kinase to give Ins(l,3,4,5,6)P5 (Verbsky et 
al., 2005b). In lower eukaryotes and plants, although this pathway exists, InsP? is 
generally produced by the phosphorylation of Ins(l,4,5)P3 at the 6’ and 3’ positions 
by IPMK to give the same product (Estevez et al., 1994; Ongusaha et al., 1998; 
Ongusaha et al., 1997).
In addition to these pathways, it is interesting that there is a further pathway for the 
production of InsPe so far only identified in plants and Dictyostelium. In the 
cytoplasm of these organisms, InsP6 is rapidly made by the sequential 
phosphorylation o f mjo-inositol. Although the path is slightly different, both require 
an initial 3'phosphorylation and involve the production of an Ins(3,4,6)P3 intermediate 
(Brearley and Hanke, 1996; Stephens and Irvine, 1990). Therefore in these organisms 
InsP6 can be synthesized by a route independent of Ins(l,4,5)P3 production and 
calcium signaling.
Why do these organisms have such a unique pathway? It is certainly no coincidence 
that both plants and Dictyostelium contain large amounts o f InsP6 -  approximately 1% 
of the dry seed weight in plants and at concentrations o f almost ImM in Dictyostelium  
(Martin et al . 1987; Raboy, 2001). One explanation is their use as an energy or 
phosphate store; both organisms have a dormant phase of their lifecycle either as a 
seed or a spore, which would be obsolete in other organisms such as yeast and 
animals. On the other hand it is highly possible that this pathway does exist at a low7
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rate in other organisms -  only metabolic emphasis has shifted for survival in their 
respective evolutionary niches.
1.9.3 Inositol phosphatases
In addition to the kinases mentioned above, there are a number of inositol 
phosphatases responsible for the converse reactions. The most versatile of these is the 
multiple inositol polyphosphate phosphatase (MIPP) family. These enzymes are part 
of the histidine acid phosphatase family and are the only known means by which 
Ins( 1.3,4,5,6)Ps and InsP6 can be broken down in the cell (Craxton et al., 1995; 
Nogimori et al., 1991). Indeed this activity was originally identified in Dictyostelium 
as a means of Ins(l,4,5)P3 synthesis in cells lacking phospholipase C activity and it 
appears to be the same activity that is upregulated in cell lacking PO and may be 
responsible for lithium resistance (Van Dijken et al., 1995a; Williams et al., 1999). In 
vitro this enzyme has been shown to act on a number of inositol phosphates, although 
greatly favouring substrates with 4 or more phosphates, and will generally attack the 
2' and then the 3' and 6' positions (Caffrey et al., 1999; Craxton et al., 1995; Yu et 
al., 2003). To date however, the in vivo role o /th is enzyme remains unclear, mainly 
due to the fact that it appears to be localized within the endoplasmic reticulum (ER), 
w here so far none of its substrates have been reported. Also, although a mouse 
knockout has been made, no phenotype was found -  possibly due to compensatory 
upregulation of a second gene (Ali et al., 1993; Chi et al.. 2000).
In addition to MIPP, another family of enzymes have been isolated which remove the 
(3-phosphate from a pyrophosphorylated inositide (Caffrey et al., 2000; Safrany et al.,
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1998). Although the regulation and cellular function of these also remains unclear, it 
seems that these enzymes along with MIPP account for all the production of InsP3 
from the higher inositol phosphates, although some 5’ phosphatase enzymes may be 
able to produce Ins(l,3,4)P3 from Ins(l ,3,4,5)P4. The phosphates remaining after 
these activities are then subsequently removed by 1 \ 4' and 5’ phosphatases. The 
most intensively studied are the 5 'phosphatases that have been shown to be active on 
lns( 1,4,5)P3, Ins(l,3,4,5)P4 and the lipids PtIns(4,5,)P: and PtIns(3.4,5)P3. These can 
be subdivided into three related classes, each with varying substrate specificity 
(reviewed in (Majerus et al., 1999)).
In addition to these there is a distinct F phosphatase, encoded by a single gene in 
mammals and able to dephosphorylate Ins(l,4)P2, Ins(l,4,5)P3 and Ins (1,3,4)P3 (Van 
Dijken et al., 1996b; Van Dijken et al., 1995b; van Haastert and van Dijken. 1997). 
This is a member o f the lithium inhibited gene family that includes IMPase, although 
structural homology seems to be restricted to the active site (York and Majerus, 1990; 
York et al., 1994; York et al.. 1995). Finally, the dephosphorylation of inositol is 
completed by the activity of IMPase. In cells, only Ins(l)P, Ins(3)P and Ins(4)P have 
been found and all o f these can be used as substrate for a single enzyme (Gee et al., 
1988; Shears, 1989). However, as with many of these enzymes, some organisms have 
multiple genes, each with different substrate preferences (Van Dijken et al., 1996b).
1.10 Inositol phospholipid metabolism
In addition to the soluble inositide pathways above, inositol phospholipid metabolism 
is also intimately interconnected (summarized in fig. 1.4). All lipid inositides can only
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be produced via myo-inositol, and therefore the recycling o f soluble forms may prove 
to be critical for lipid signaling. Ptlns synthesis occurs in the endoplasmic reticulum 
by the fusion of cytidine diphosphodiacyglycerol (CDP-DAG) and myoinositol by PI 
synthase (Gaigg et al., 1995; Gardocki et al., 2005; Zinser et al., 1991) and is then 
transported to the plasma membrane where the various phosphatases and kinases act.
At the plasma membrane, Ptlns is then phosphorylated at either the 3! or the 4 ’ 
positions by class II PIS’kinases or PI4’kinases respectively. These two pathways are 
then extended by further phosphorylation, either by PIKfyve/fabl 5’kinases to form 
Ptlns(3,5)P2 and mediate endosomal trafficking, or PI-5-kinase to form PtIns(4,5)P2 
(Desrivieres et al., 1998; Homma et al., 1998; Ikonomov et al., 2003; Odorizzi et al., 
1998; Odorizzi et al., 2000; Sbrissa and Shisheva, 2005). As described previously, 
PtIns(4.5)P3 is a central molecule in a number signaling pathways - as a substrate for 
PLC to invoke calcium signaling, for the regulation of actin dynamics and as a 
precursor for PtIns(3,4,5)P3 production (Nebl et al., 2000; Ostrander et al., 1995; 
Sciorra et al., 1999). In higher eukaryotes (yeast lack the enzyme), extracellular 
stimuli are then able to activate the class I PI3' kinases through G-protein coupled 
receptors, producing PtIns(3,4,5)P3 and initiating a whole range of cellular signaling 
events (Leevers et al., 1999; Shepherd et al., 1998). In order to restrict and/or 
terminate the signal, PtIns(3,4,5)P3 is then broken down by the actions of either the 
tumour suppressor PTEN (phosphatase and tensin homologue) , or SHIP (SH2- 
containing inositol phosphatase) - removing the 3' or 5’ phosphates respectively 
(Maehama and Dixon, 1999; Pesesse et al., 1998).
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Although some of these molecules, such as PtIns(4,5)P2 are precursors for the 
production of second messengers, the most important role for many of these lipids is 
the recruitment of proteins to specific parts of specific membranes. This is done 
through conserved lipid-binding domains, most notably pleckstrin homology (PH) 
domains and are involved in a number of processes including, chemotaxis, 
endocytosis, phagocytosis and cytokinesis. PH domains are structurally conserved 
modules of approximately 100 amino acids that bind to the head groups of inositol 
lipids, and it has recently been argued, soluble inositol phosphates (Kavran et al.,
1998: Lemmon et al., 1996; Razzini et al., 2000). Many PH-domain containing 
proteins have been identified and although a common structure is conserved, subtle 
differences lead to different binding preference, and therefore localization.
1.11 Complexity in inositol metabolism and signalling
One of the more distinctive features of inositol phosphate metabolism is its 
complexity and the variety of signaling pathways that can be regulated. This is further 
compounded by the fact that many of the enzymes can use multiple substrates and 
produce multiple products. For example, the Ins(l,3,4)P3 5/6 kinase family of 
enzymes have been reported to also be able to use Ins(l,4,5)P3 and Ins(3,4,5,6)P4 as 
substrates, adding phosphates at the 3? and 1’ positions respectively (Field et al.,
2000: Yang and Shears, 2000). In addition, some of the enzymes involved in inositol 
metabolism have dual functionality, such as IPMK which was first identified as Arg82 
- involved in the transcriptional regulation of arginine metabolism in S. cerevisicie, an 
activity which is independent of inositol kinase activity (Dubois et al., 2000). In 
addition, it has been suggested that Ins(l,3,4)P3 5/6 kinase can also act as a protein
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kinase, although the data for this is conflicting (Caffrey et al., 2001; Resnick et al., 
2005; Wilson et al.,2001).
Inositol phosphate metabolism is further complicated by the fact that many proteins 
may not distinguish between soluble and lipid inositides. In vitro studies have shown 
that MIPP, IPMK and PTEN are all able to use both as substrates and there are also 
indications that the pyrophosphates may be able to compete for the lipid binding of 
PH-domains (Caffrey et al., 2001; Luo et al., 2003). Whether this proves to be 
significant in vivo may be debatable, particularly as many of the enzymes have a 
highly regulated localization as well as spatial and temporal activation, but it does 
suggest the possibility that the relative levels of soluble and lipid inositides may be 
able to affect the signaling of the other and it may well be naive to think of each in 
isolation. In addition, inositol signaling is an extremely robust system, and often 
there is a significant degree redundancy between enzymes, or alternative pathways 
such that when the system is perturbed, homeostasis and signaling can be maintained.
1.12 Regulation of phospholipid synthesis
Inositol signaling is important for a number of cellular process and therefore the total 
amount of inositol within the cell is carefully maintained. In addition to the recycling 
pathway of inositol lipids, myo-inositol is made de novo from glucose-6-phosphate by 
the action of inositol synthase, producing Ins(3)P which is subsequently 
dephosphorylated by IMPase. As IMPase is inhibited by lithium and inositol synthase 
is indirectly inhibited by VPA, this pathway is a common target for both drugs and 
therefore is a good candidate for the action of these drugs on aggregation.
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Inositol synthase is the protein product of the ino-l gene - disruption of which leads to 
inositol auxotrophy in both yeast and Dictyostelium (Fischbach et al., 2006; Hirsch 
and Henry, 1986). The expression of ino-l is tightly regulated by a number of factors 
involved in sensing the inositol and lipid status of the cell. Upon addition of inositol 
to the medium of yeast, expression of ino-l is repressed 12-fold, an effect which is 
amplified to 33-fold if choline is included as well (Hirsch and Henry, 1986). In the 
absence of inositol, transcription is derepressed by the binding of the transcriptional 
activators Ino2p and Ino4p as a heterodimer to the U A S in o  sequence, found upstream 
o f ino-l and other inositol-sensitive genes, including Ino2 (Ambroziak and Henry, 
1994). Upon addition of inositol, transcription is blocked by the translocation of a 
further element, Opilp, from the ER to the nucleus where it is able to mediate 
repression though a direct interaction with Ino2p (Gardenour et al., 2004; Heyken et 
al., 2005). O pilp is used as a sensor of the lipid status of the cell and is regulated by 
interaction with ER-protein including the proteins vesicle-associated-membrane 
protein associated protein (VAP), Scs2p and phosphatidic acid (Loewen et al., 2004; 
Loewen et al., 2003). In addition, it has also been shown that O pilp  can be 
phosphorylated by protein kinases A and C and casein kinase II, altering its ability to 
repress transcription (Chang and Carman, 2006; Sreenivas and Carman, 2003; 
Sreenivas et al., 2001).
As this procos is designed to up-regulate inositol production when intracellular levels 
of inositol are limiting, it is perhaps no surprise that treatment with lithium and VPA 
also increases the expression of ino-l and ino-2, although not sufficiently to stop 
inositol depletion (Vaden et al., 2001). However, upon disruption of the yeast opil
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gene, ino-l becomes constitutively expressed, which leads to increased resistance to 
growth in lithium and therefore a similar mechanism may also be responsible for 
lithium resistance in Dictyostelium.
1.13 Inositol phosphates and the nucleus
Recently it has emerged that in addition to the roles of inositol lipids and phosphates 
in the cytosol and at the plasma membrane, there is a distinct nuclear pool of 
phosphoinositides, independent from the rest of the cell, with its own quite separate 
metabolism (reviewed in (Cocco et al.. 2004; Hammond et al., 2004; York. 2006)). 
This nuclear pool has been shown to be important for a number of nuclear functions; 
in yeast loss of either PLC, IPMK or InsP5 2' kinase results in defective mRNA 
export (Odom et al., 2000; York et al., 1999) and the pyrophosphates appear to be 
involved in both telomere maintenance and DNA repair (Luo et al., 2002; Saiardi et 
al.. 2005; York et al., 2005) although the mechanisms of these are unclear.
In addition, both the higher order inositol polyphosphates and the enzymes involved 
in their metabolism are involved in transcriptional regulation. For example, IPMK 
was also identified as a transcription factor involved in the regulation of arginine- 
responsive genes, known as Arg82 and associates with the ArgR-Mcml complex 
required for an arginine-specific transcriptional response (Yoon et al., 2004). 
Interesting!}. the recruitment of this complex to arginine responsive DNA elements 
and transcriptional regulation requires IPMK/Arg82 protein but not kinase activity 
and therefore it appears that IPMK/Arg82 has two independent functions (Dubois et 
al., 2000; El Alami et al., 2003).
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IPMK/Arg82 and changes in the higher order inositol polyphosphates have also been 
implicated in transcriptional regulation via chromatin remodeling complexes. In 
eukaryotic cells the DNA is tightly wrapped around nucleosomes and thus packaged 
into chromatin. In the nucleus this is generally repressive to transcription by limiting 
the access of the RNA polymerase machinery to the DNA. Therefore there are many 
complexes of proteins whose function it is to move these nucleosomes along the 
DNA. Using the energy from ATP hydrolysis, these complexes move the 
nucleosomes out o f the way, unblocking the promoter sites and leaving the DNA 
accessible for transcription (Fyodorov and Kadonaga, 2001; Olave et al., 2002).
In a study by Shen et al. it was demonstrated that in vitro, different higher order 
inositol polyphosphates can directly interact with and either activate, or inhibit 
chromatin remodeling complex activity at the Ino-l promoter. In this study it was 
seen that the ATPase and nucleosome mobility activities of the NURF, ISW2 and 
INO80 complexes is directly inhibited by InsP6 , but no other inositides. Conversely 
they also demonstrate that the remodeling activity of the Swi/Snf complex was 
stimulated by both Ins(l,4 ,5 ,6 )P4 and In s(l,3,4,5,6 )P5 although this time 
independently of ATPase activity (Shen et al., 2003). Others have shown that in vivo 
the induction of the yeast pho-5 gene requires the inositol kinase activity of 
IPMK/Arg82. as well as PLC (Auesukaree et al., 2005), and Steger et al. went on to 
demonstrate that null mutations o f these genes reduce the recruitment of INO80 and 
Swi/Snf complexes to this promoter. This therefore again points towards a role for 
InsP4 and/or InsP.s production in chromatin remodeling, although this time they found 
no requirement for InsP6  production (Steger et al., 2003). These experiments would
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therefore predict that under conditions with high nuclear InsP4 and InsPs and low 
InsP6. expression is increased. In addition to this, other studies have also found that in 
lymphocytes, nuclear PtIns(4,5,)P: can also regulate the binding of the Brahma 
associated factor (BAF) complex (of the Swi/Snf family) to chromatin (Zhao et al., 
1998). And therefore changes in the nuclear inositol metabolism may be responsible 
for transcriptional regulation on a genome-wide scale co-ordinately regulating the 
metabolism of inositol, phosphate and arginine.
If these processes prove to be significant in vivo, they indicate mechanisms by which 
inositol metabolism may affect gene expression, potentially across the whole genome 
and potentially explains some of the transcriptional changes observed upon the 
chronic lithium treatment of both mice and Dictyostelium (Bosetti et al., 2002; Keim- 
Reder, 2006). Therefore, in addition to a direct effect on cell signalling, changes in 
inositol metabolism may also induce transcriptional changes and alter cell behaviour - 
potentially providing an alternative mechanism for how alterations in higher order 
inositol polyphosphate metabolism, as seen in the PO mutant, may confer drug 
resistance.
1.14 Aims of this study
In Dictyostelium the loss of prolyl oligopeptidase activity confers resistance to the 
effects of lithium and VPA on aggregation. These cells also have elevated 
Ins(l,3,4,5,6)P.s phosphatase activity resulting in increased Ins(l,4,5)P3 production 
and therefore it is likely that this is may be able to compensate for the inositol- 
depleting effects of both drugs. The aim of this study is to clone the MIPP gene
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responsible for this activity, and by generating null and overexpressing mutants, 
determine the effect altered MIPP activity has on lithium sensitivity. If MIPP activity 
proves to be important for lithium resistance, the role of the higher order inositol 
phosphates and the mechanism of resistance will be investigated by generating further 
mutants in other genes involved in their regulation such as the inositol polykinases.
In addition, the ability of lithium and VPA to inhibit aggregation indicates that the 
recycling of inositol and the synthesis of new phospholipids may have an important 
role in cell migration. PLC represents the major link between inositol lipid signaling 
and the soluble inositides and loss of this gene should result in reduced inositol 
recycling. Therefore by studying the effect of this mutation on lithium resistance, the 
roles of both PLC and phospholipid recycling on cell movement will hopefully be 
better understood.
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Chapter 2: 
Materials and methods
2.1 Bioinformatics
Indentification of Dictyostelium homologues was done using the Blast portal on the 
Dict\ base website (www.Dictybase.org) (Altschul et al., 1997). Where known, the 
conserved or catalytic domains of proteins in other species were used to search the 
predicted protein database. If such details were unavailable, whole protein sequences 
were used and the “expect value” decreased until some potential proteins found. In 
this case, Dictyostelium  homologues were verified by comparison with the same 
protein across evolution. Dictybase reference codes are given for all Dictyostelium 
genes. Alignments were constructed using the Clustal algorithm as part of the 
MacVector 7.2 software suite (Accelerys).
2.2 Dictyostelium cell culture
Dictyostelium cells were grown axenically in either HL-5 medium (14 g/L proteose 
peptone, 7 g/L yeast extract, 13.5 g/L glucose, 0.5 g/L Na:HP 0 4 , 0.5 g/L K FfPC L.pH  
6.4.) for normal culture and antibiotic selections, or in FM minimal medium 
(Formedium) which contains no inositol, prior to inositol phosphate determination. 
Cells were also grown and allowed to develop on SM agar plates (10 g/L proteose 
peptone, 1 g/L yeast extract, 10 g/L glucose, 1.9 g/L KH2PO4, 1.3 g/L K2FIPO4.3FI2O, 
0.49 g/L MgSCL, 17 g/L agar) on a lawn of Klebsiella aerogenes by standard 
methods.
In all cases, except where otherwise stated, the AX2 strain was used as wild-type and 
is the parent of all mutants. Cells were both starved and washed in KK2 buffer (16.5
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mM KH2 PO4 , 3.8 mM K2 HPO4 pH 6.2). When required, cells were pelleted by 
centrifugation at 700 x g for 2 minutes.
2.3 RNA extraction and cDNA synthesis
Prior to extraction, 5 x 106 cells were seeded in a 10cm Petri dish and left to grow 
overnight. The following day, cells were pelleted and washed once in KK2 buffer 
before total RNA extraction using a Roche kit. RNA quality was then checked by 
running lu l on a 1% agarose/ethidium bromide gel. Any samples lacking two clear 
ribosomal bands were discarded. RNA was then quantified by measuring absorbance 
at 260 and 280nm in a spectrophotometer. Reverse transcription was done using lpg  
total RNA using first strand synthesis kit (Roche) as per the manufacliters 
instructions. In all cases random primers were used.
2.4 PCR analysis of expression
To check for expression of each gene. cDNA was analysed by PCR. For each gene the 
following primer pairs were used to generate a 400-600bp specific product for each 
gene: mppA GTGTACCCTATCCAAGTGATA / TACTTAGAAGTGAACACCAA 
TG; mppB TATTGGTCGTCATGGTTCAAGA / C ATT GT C ATT A ATT GATT GAT 
CTCG; ipkAl T AG f  CC ACC AT C AT CCA AT G A / GAATGTGGTTTCATATGAG 
ATGG; ipkA2 AATGGGTGTAAGACAGCACG / GAGTAAAAGTGAACCACCA 
TAG; ipkA3 GTGGTGCAAAACTTGTGCATCC / G AGTT A ATGG AT CT AC AT G 
AGCG; ipkB CTAACTGATGAGTTAGGTGAC / GCGTTATGATTAA 
TGAACTCTTG.
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PCR conditions used were 30 cycles of 92° x 1 min., 52° x 1 min. and 68° x 1 min. 
Biotaq DNA polymerase (Bioline) was used in the supplied buffer supplemented w'ith 
2 mM MgCl. 0.1 mM dNTP’s and 0.4mM each primer. lOng cDNA was used as 
template in all reactions. PCR products were then examined using ethidium bromide 
in a 1.5% agarose gel.
2.5 Extraction of genomic DNA
For use as either a PCR template or for Southern blotting, 107 cells were pelleted and 
washed once in KK2 before being dissolved in 1ml DNAzol reagent (Invitrogen). Cell 
debris was then removed by centrifugation at 15,000 x g, and DNA precipitated from 
the supernatant by the addition of 0.5 ml 100% ethanol. This was left for 5 minutes at 
room temperature before centrifugation at 15,000 x g for 5 minutes. The DNA pellet 
was then washed once in 70% ethanol and finally dissolved in lOOpl 8mM NaOH.
The pH was then adjusted to 7.0 using 3.2pl 1M HEPES buffer.
2.6 General cloning
Throughout this project, all plasmids constructed were primarily screened by 
restriction digest. All enzymes were supplied by New England Biolabs and used in 
the appropriate buffer. For screening of plasmid clones, approximately 0.5 pg of 
DNA from each was digested with enzyme and analysed by agarose gel 
electrophoresis. Clones to be used for protein expression were then subsequently 
sequenced. Ligations were carried out at room temperature for approximately 3-4
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hours using T4 DNA ligase (New England Biolabs). Generally a 3:1 molar ratio of 
vector : insert was used.
2.7 Cloning of mppA and generation of knockout and overexpression constructs
A full-length clone of mppA was made by PCR from genomic DNA using the primers 
CACA AACCAACTATGATGGTAAAAAT / TTATTGGATCAATGGAGATCT - 
TGA. This was then cloned into the TOPO blunt II vector (Invitrogen) as per the 
manufacturers instructions, sequenced and used as the starting clone for all other 
constructs. To facilitate PCR screening of potential disrupted clones, the full-length 
clone was first truncated at its 3’ end by digestion with Bglll and BamHI restriction 
enzymes and subsequent re-ligation. The loxP flanked blasticidin selection cassette 
from pBLPBSR (Faix et al., 2004) was then excised by Smal digest and inserted into 
the middle of the middle o f this truncated mppA clone at the BstBI site, which was 
blunted using Klenow. The Blasticidin cassette was found to be inserted in the same 
orientation as the mppA gene, and this construct was named pJSKl 16. The entire 
disruption construct was then excised from the vector backbone by Notl digest prior 
to Dictyostelium transformation.
fo generate a completely untagged, full-length mppA expression construct the RHI8 
vector was used (a gift from R. Insall, unpublished). This is a G418 selectable, Ddpl- 
based episomal plasmid using an actinl5 promoter to drive expression of a gene of 
interest.
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Wild-type genomic DNA was used as template to generate a full-length clone of 
mppA with additional 5’BamHI and 3’ Notl restriction sites. PCR was done as 
normal, using the acuzume proofreading polymerase (Bioline) and the following 
primers: GGATCCCACAAACCAACTATGATGGTAAAAAT / GCGGCC 
GCTT ATT GG AT C AAT GG AG AT CTT G A AT C. The PCR product was then gel- 
purified and cloned into TOPO blunt II (Invitrogen) before validation by sequencing. 
This was then cut with BamHI and Notl and ligated into RHI8 cut with the same 
enzymes to generate the final construct, named pJSK 166.
2.8 Construction of Inositol kinase overexpression constructs
For expression in Dictyostelium, the pTX-FLAG episomal vectors were used (Levi et 
al., 2000). A full-length genomic clone of ipkB was obtained from wild-type cells 
using the primers: AT GGGT C G A AAT AAT AC ATT AC / GTTTTT AT ACC 
GATGAT TTTCTT, and subsequently clones in the TOPO blunt II vector (pJSK 
102). A 5'BamHI restriction site in frame with the initiating ATG was then added by 
using this as a template for PCR using the GGATCCATGGGTCGAAATAATACA 
TTAC and the initial reverse primer and again cloned into TOPO blunt II (pJSKl 14). 
The whole gene was then cut out with BamHI and Xho I (from the TOPO multiple 
cloning site) and ligated into pTX-FLAG cut with the same enzymes (pJSK l23).
The ipkA 1 expression vector was cloned in an identical fashion except that the 
original clone used was the cDNA obtained from the Japanese cDNA sequencing 
constortium (CHB152). The intermediate clone, made using the primers 
GG ATCC AT G AAT G ACC A A A AT A A ATTT C A AG / CTCG AGTTTTTGTGGT
4 2
TGTTGAGGTTGTTG, to add 5’ BamHI and 3’ Xho I restriction sites was named 
pJSK l30, and the final N-terminal FLAG fusion plasmid pJS K l34.
2.9 Construction of a PLC knockout construct
The pic knockout vector was made with a few refinements for ease of cloning. Two 
regions of the pic  gene, at the 5’ and 3’ends were amplified from wild-type genomic 
DNA using the following primers: 5' fragment -  GTCGATTTATCATTAG 
AATCATTAGC / AG AT CTT ACGTCGACCC ATCCC A AACGTCC A ATTC AACG 
C; 3' fragment -  GTCGACGTAAGATCTCTTCACCATATCCTGTCATACTCAG / 
GGAATTGCATTCATTTTCTTTGTATC. These two segments do not cover the 
whole gene such that a double crossover event into the genomic locus will result in a 
deletion of lOObp o f sequence and the 5’ fragment was designed to start just after the 
5' end of the gene so that further primer could be used for screening.
The PCR primers were also designed such that Sail and Bglll sites were added to the 
3 'end of the 5' fragment and the 5’end of the 3’ fragment. This overlapping sequence 
means that the two fragments could be combined by PCR, by mixing the two 
fragments together and using the two end primers. This product was then cloned into 
the TOPO blunt II vector (Invitrogen). Finally, this plasmid was cut with Sall/Bglll 
and the lo\P  -  flanked blasticidin cassette from pBLPBSR was excised by 
Sall/Bamlll digest, gel purified and ligated in. This final construct (pJSK l63) was 
then cut with EcoRI to release the knockout cassette before transformation.
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2.10 Dictyostelium  transformation
Cells were transformed by electroporation as previously described (2002). Briefly,
107 cells, growing in log-phase were washed once in ice-cold electroporation buffer 
(50 mM sucrose in KK2) before being resuspended in a final volume of 800pl in an 
electroporation cuvette. For integrating plasmids, 20pg and for episomal plasmids 
lOug DNA was then added and incubated on ice for 10 minutes. Cells were then 
electroporated at lkV before a further 10 minute incubation on ice. The cells were 
then transferred into a 10cm petri dish and 8pl of salt solution (0.1 M M gCf, 0.1 M 
CaCF) added. After 20 more minutes the cells were then finally resuspended in 10 ml 
HL-5 medium.
After 24 hours, transformations o f knockout vectors were cloned into 6 x 96 well 
plates in the presence o f 10 pg/ml blasticidin S. After approximately 2 weeks, 
multiple clones were seen and transferred into individual wells o f a 24 well plate for 
screening. Transformations with episomal expression vectors were simply expanded 
in 10cm dishes and selection started 24 hours post-transformation with 20 pg/ml 
G418. Due to the extrachromasomal nature of these vectors, all clones should have 
the same copy number and have no positional effects. Therefore, sub cloning is 
unnecessary and all colonies produced were pooled.
2.11 Screening of mppA and pic knockout clones
After the isolation of independent clones, each was grown in 1ml culture in a 24 well 
plate. When each wells became confluent, they were resuspended and the cells
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harvested into microfuge tubes. Medium was replaced in each well so that the 
residual cells would repopulate. The harvested cells were then pelleted and 
solubilized using 250pl DNAzol reagent (Invitrogen). Genomic DNA was then 
precipitated by addition of 125 ul 100% ethanol and incubater at 22°C for 10 minutes. 
DNA was pelleted and washed once in 250 pi 70% ethanol before dissolving in 20pl 
8mM NaOH (freshly prepared).
To differentiate between integration at the desired locus or at a random position, the 
configuration of the genomic locus was analysed by PCR. As the mppA knockout 
construct was truncated at its 3’end, the original primers used to obtain the initial 
genomic clone could be used as only the endogenous locus will give a product. The 
pic knockout construct is also slightly truncated at its 5’end and therefore the 
following primers could be used : AT GGAT ACTTT A AC AA ATTCCC AAG / GAT 
GACCAATTCTATTGTGACCAAC, again as the 5’primer will not bind the original 
construct, only the genomic locus will be amiplified. In both cases, homologous 
recombination and integration of the blasticidin cassette, will lead to a 1.3Kb increase 
in the size of the PCR product.
Therefore 1 ul of genomic DNA from each sample was used as template for PCR 
using Biotaq polymerase (Bioline). The conditions used were: 30 cycles of 92° x 1 
min.. 49° x 1 min. and 68° x 1.5 min. The supplied NH4 buffer was again 
supplemented with 2 mM MgCl, 0.1 mM dNTP’s and 0.4mM of each primer.
2.12 Southern blotting
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Positive mppA knockout clones were verified by Southern blot. Genomic DNA from 1 
x 107 cells was cut overnight at 37° with Clal and Spel restriction enzymes, run on an 
0.6% agarose gel and blotted onto nitrocellulose membrane by standard methods 
(Southern. 1975). A probe was then generated using the 500bp PCR product 
generated by the primers: GTGTACCCTATCCAAGTGATA / TACTTAGAAGTG 
AACCCAATG with the knockout construct as template. PCR was done using Biotaq 
as described above. The PCR product was then purified using a G-50 column 
(Amersham Biosciences), and the megaprime kit (Amersham Biosciences) used to 
label it with 32P as per the manufacturers instructions, using random primers. This was 
again purified with a G-50 column and boiled for 5 minutes before addition to Church 
hybridization buffer (0.5 M Na2H P 04, 7% SDS, 1 mM EDTA) (Church and Gilbert, 
1984).
The blot was then incubated with the probe at 65°C overnight, before washing twice 
with 2 x SSC, 0.1% SDS and twice with 0.5 x SSC, 0.1% SDS (20x SSC stock: 3 M 
NaCl. 0.3 M sodium citrate, pH 7.0). The membrane was then examined using a 
phosphoimager screen.
2.13 MIPP activity assays
MIPP activity assays were essentially done as in (Van Dijken et al., 1995a) with a few 
refinements. Protein samples were prepared by resuspending cells at 2 x 108 cells /ml 
in TEE (20mM triethanolamine pH6.5, 5.9mM EGTA, 0.5mM EDTA) and lysing 
them through nucleopore filters (5pm pore size). Samples were then centrifuged at 
100,000 x g for 30 minutes, and the superatant removed. Pellets were then
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resuspended in the original volume of TEE and equal protein levels between samples 
verified by Bradford assay.
Unless activity was to be analysed by HPLC, MIPP activity was determined by the 
rate of Ins( 1,4.5)P.i production, as measured using the isotope dilution assay. Reaction 
conditions were as follows: cell extracts were mixed with an equal volume of TEE 
supplemented with 20mM CaCl, 50mM LiCl and 200pM InsP6 (final substrate 
concentration lOOpM). 50pl samples were removed at the start and after 30 minutes, 
and were immediately quenched by the addition of lOul ice-cold 100% (w/v) 
trichloroactetic acid (TCA). Quenched samples were then mixed, and left on ice for 
10 minutes before the addition of 440pl water. Precipitated protein was removed by 
centrifugation and TCA removed by solvent extraction using 1ml o f 3:1 1,1,2- 
trichloro-1.2,2 trifluoro ethane : trioctylamine. Ins(l,4,5)P3 levels were then 
determined using the isotope dilution assay (Perkin Elmer) as per the manufacturers 
instructions.
For HPLC analysis, the reactions were set up as above with the exception that in order 
to prevent InsP6 precipitation, the final C aC f concentration was reduced to ImM 
C'aCF (although reaction efficiency is maintained) and the reaction samples were 
quenched in an equal volume of 20% (w/v) TCA + 2mM EDTA. Precipitated protein 
was removed by centrifucation and TCA was then largely removed by four sequential 
extractions in two volumes of diethyl ether (retaining the lower phase), and pH 
returned to neutrality using 0.5M triethamolamine pH 8.0. Samples were then 0.2 pm 
filtered before HPLC analysis as described below.
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2.14 Prolyl oligopeptidase activity assays
For PO assays. 2 x 107 cells were harvested, washed once in KK2 and snap frozen on 
dry ice. Cells were then resuspended in 50 mM Tris pH7.4, ImM EDTA 
supplemented with protease inhibitors (ImM  dithiothreitol, 5 pg/ml aprotinin, ImM 
benzamidine, 10 pg/ml leupeptin and O.lmM AEBSF) and lysed by sonication (3 x 
10 seconds on ice). Particulate debris was then removed by centrifugation at 15,000 x 
g for 35 minutes at 4 °C and protein levels in the supernatant quantified by Bradford 
assay (using BioRad reagent).
PO activity was then measured by cleavage of Z-gly-Pro-pNA (Bachem) to form the 
coloured product p-nitroaniline (Makinen et al., 1994). 2.5 pg of protein was 
incubated with 141 pM Z-gly-Pro-pNA (dissolved in methanol) in 50 mM HEPES 
pH 7.8. ImM EDTA and ImM DTT, 0.25% dimethylsulphoxide in a 60pl reaction 
for 90 minutes at 37°C. Reactions w'ere then quenched with 200 pi 1.5M acetic acid 
and the absorbance at 490 nm measured. Duplicate reactions were also set up and 
quenched immediately and these were subtracted to give an absolute reading. Activity 
was subsequently calculated as a percentage of that in wild-type cell extracts.
2.15 Extraction of Inositol phosphates for HPLC analysis
For the quantitation of intracellular inositol phosphates, cells were harvested from 
bacterial clearing plates, thoroughly washed free of bacteria and pellets of 1 x 109 
cells snap— frozen on dry ice. Upon defrosting, cell pellets were resuspended in 1ml 
ice-cold 20% (w/v) trichloroacetic acid, 5mM NaF and incubated in ice for 15
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minutes. At this stage samples were routinely spiked with an internal standard of 
7nmol Ins(l ,4.5,6)P4 as none was detectable in any of the mutants used. Samples were 
then spun at 15,000 x g for 10 minutes at 4°C, the supernatant transferred into a new 
tube and the extraction repeated again. The two supernatants were then combined and 
the TCA largely removed as before by four sequential extractions in two volumes of 
diethyl ether. Sample pH was then returned to 6.0 using 0.5M triethanolamine pH 8.0 
and the extracts were freeze-dried.
Nucleotides were then removed by charcoal extraction. Lyphilised samples were 
resuspended in 400pl pellet wash (0 .1M NaCl, 15mM NaF, 0.5mM EDTA pH 6.0), 
and treated three times with 150pl charcoal suspension (O.lmM NaCl. 50mM sodium 
acetate, 20% w/v acid-washed Norit A, pH4.0). Charcoal was removed by 
centrifugation at 13.000 rpm for 5 minutes at 4°C in a microfuge. Pellets were 
retained and sequentially resuspended in 1 OOpl pellet wash which was then combined 
with the cell extract. All samples were then filtered to 0.2pm before injection. 
Quantification of the internal control indicated that consistently over 70% of the 
sample remained after extraction. After quantification, most of the variability 
appeared to come from the batch o f SM nutrient agar on which the cells were 
originally grown, and therefore in each case control cells were grown and extracted in 
parallel.
2.16 HPLC-MDD analysis
Quantification of inositol phosphates by metal-dye detection was based on that 
described in (Casals et ah, 2002; Guse et ah, 1995; Mayr, 1988) using Tricorn Mini Q
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4.6/50 PE columns (Amersham/GE healthcare). Chromatography solutions used were 
A: (21uM YCI3 ) and B (0.8M HC1, 25pM YCI3 ) and the post-column detection 
reagent was C (2.13M triethanolamine, 500qM 4-(2'-Pyridylazo)-Resorcinol (PAR), 
pH 9.75). Elution o f inositol phosphates were detected by a drop in absorbance at 
520nm. although for ease of analysis, the connection to the computer was reversed 
such that this becomes a peak. All reagents were of analytical grade and supplied by 
Merck unless otherwise stated. Flow rate was maintained at lml/min (A/B) and 0.4 
ml/min C and the gradient used was as follows (time(min):%B): O’ -1 %, 4 ’ -1 %, 6 ’- 
2.5%. 7'-2.5%. 8 ’ -4 % , 1 0 '-5 % , I E -5 .5 % . 12’ - 6.2%, 13’ -8 .5 % , 15’ -1 0 % ,
19' -  11.2%, 20’ -  13.7%, 25’ -  14%, 35' -21 .2% , 41’ -3 5 % , 45’ -3 6 % , 50’ -  
50%, 60’ -  90%, 65’ -  100%. This gradient was sufficient to separate all 
phosphorylation states, including the pyrophosphates and many of the isomers of each 
phosphorylation state. Where possible, peaks were identified using authentic 
standards, if this was not possible, as the order of elution remains constant between 
systems, peaks were identified by the order in which they eluted compared to a partial 
hydrolysis of InsP6  reported in (Hull et ah, 1999) and other studies.
For quantification, in the middle of each sample set a four-point calibration was run 
using 0.5. 1, 2 and 4 nmoles each of Ins(l,4 ,5 )P3 , In s(l,5 ,6 )P3 , In s(l,3 ,4 ,6 )P4 ,
Ins( 1,2,5,6)1% Ins(l,4 ,5 ,6 )P4 , In s(l,2,3,4,6 )P5 , Ins(l,3 ,4 ,5 ,6 )P5 and InsP6 (Cell 
Signals Inc.). The area of each peak on each chromatogram was then calculated using 
the Star software suite (Varian), and used to verify a linear response and generate a 
calibration curve for each phospho inositide. To quantify inositol phosphates other 
than those commercially available or included in the calibration, a calibration curve 
was estimated from similar isomers. In the case of the InsPy and InsPs as no isomers
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are commercially available, calibration was estimated from the InsP6 values corrected 
for phosphate content. For quantification of cell extracts, a 500pl injection was used 
(the extract from approximately 7 x 108 cells), both of neat sample and a 1:10 dilution 
and samples were normalised for extraction efficiency using the internal control. For 
analysis of enzyme assays, all samples were also diluted for 500pl injections.
2.17 Determination of intracellular and secreted Ins(l,4,5)P3 levels
For the specific measurement o f Ins(l,4,5)P3 the isotope dilution assay was used. For 
the determination of intracellular Ins(l,4,5)P3 levels, exponentially growing cells 
were pelleted, washed once in FM minimal medium, and resuspended at 5 x 106 
cells/ml in KK2 buffer. Cells were then placed in shaking flasks for 10 minutes to 
allow any effect of cell stress to be neutralized. 1ml samples were then taken and 
immediately extracted by addition of 200pl 100% trichloroacetic acid (TCA). TCA 
was then largely removed by solvent extraction in twice the equivalent volume of 3:1
1.1,2 trichloro 1,2,2 trifluoro ethane : trioctylamine.
For the measurement of secreted Ins(l,4,5)P3, log-phase cells were washed and 
resuspended at 3 x 10b cells/ml in 10 ml FM minimal medium. Cells were then placed 
in shaking Tasks and lml samples removed at the time intervals indicated. Cells were 
quickly removed from samples by centrifugation at 10,000 x g for 30 seconds in a 
microcentrifuge and the supernatant removed to a fresh tube. Inositol phosphates in 
the supernatant were then extracted in 100% TCA and neutralized as above. Samples
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were then quantified using the isotope dilution assay (Perkin-Elmer) as per the 
manufacturers instructions.
2.18 Western blotting
For western blotting, cells were lysed in Laemelli buffer (50 mM Tris-HCL pH 6.8, 
100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) and boiled 
for 5 minutes to denature proteins before running on a 10% polyacrylamide gel. The 
protein from 2 x 105 cells was loaded per lane. Western blotting was then carried out 
using standard methods, and probed with either a rabbit a-PLC antibody (Gift from 
P.J.M Van Haastert (Drayer et al., 1994)) followed by a secondary horse raddish 
peroxidase (HRP)-conjugated a-rabbit antibody (Sigma), both used at 1:10,000; or 
HRP conjugated a-FLAG antibody (Sigma) used at 1:1,000 dilution. In all cases 
Pierce ECL reagent was used as HRP substrate.
2.19 Analysis of cell movement
For analysis of random cell movement, 24 hours prior to analysis, cells were seeded at 
3 x 105 /ml in FM minimal medium. On the day of the experiment, the cells were 
resuspended and 40 pi transferred to a glass-bottomed chamber slide (Lab-Tek) 
containing 2 ml medium. Cells were then left for 30 minutes to attach and recover 
before the medium was aspirated and replaced with KK2 containing either sodium or 
lithium chloride. They were then left for 1 hour before analysis.
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For chemotaxis assays, growing cells were washed once and resuspended at 5 x 106 
cells /ml in KK2. Cells were then shaken for 5 hours and subjected to 100 nM cAMP 
pulses at 6 minute intervals. LiCl treatment was included for the final hour only. After 
5 hours a small number of cells was then allowed to adhere to a glass slide before 
being exposed to a cAMP gradient using a Zigmond chamber (Zigmond, 1988).The 
chamber was set up with lpM  cAMP (in KK2) on one site and KK2 on the other and 
left for 15 minutes before analysis.
In all experiments DIC images were taken using an Olympus 1X71 inverted 
microscope with a 20x objective (NA 0.45). As our microscope is equipped with a 
motorized stage. 8 fields of view were taken simultaneously for each sample. Images 
were captured every 10 seconds for 10 minutes. DIAS 3.4.1 software (Soli 
Technologies Inc.) was then used to analysis the images. In this analysis, for each 
frame of the movie each cell was automatically outlined and cell paths determined. At 
this stage any cell that contacts another was disregarded. The average speed, 
persistence, acceleration, direction change, roundness and chemotactic index over the 
10 minute period was calculated for each cell and in every case a minimum of 50 cells 
were measured and averaged. All experiments were repeated at least 4 times and, 
normalized to a NaCl control value as indicated. In all cases statistical analysis was 
done using an unpaired 2-tailed T-test.
2.20 Quantitative real-time PCR analysis
Total RNA was isolated from Dictyostelium  as follows: 5 x 106 cells were seeded in 
10cm petri dishes and allowed to grow axenically overnight in the presence or
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absence of the appropriate inhibitors. 16 hours later cells were harvested by 
centrifugation and washed once in KK2. RNA was then extracted and cDNA 
synthesized as described in section 2.3.
Q-RT PCR was then performed using lOng cDNA as a template and a SYBR green 
mastermix kit (Abgene) on an Opticon 2 instrument (MJ Research). All reactions with 
PCR products between 100-200 bp were run for 35 cycles using the following 
program: 95° x 15 sec, 57°x 15 sec. 70° x 20 sec. Reactions giving products of 300- 
500 bp were all used the same program but with extension at 70°C for 30 seconds. 
Each reaction was then subjected to melting curve analysis, to verify product quality.
All samples were run in triplicate, and in at least 3 independent experiments. Fold 
changes were calculated using the 2'AAcT method (Livak and Schmittgen, 2001) using 
the mean c(T) value from each run and normalised to Ig7 as a loading control. Note 
that to maintain comparable product sizes for all genes, when ipmaL ippA/B and inol 
primer sets were used, the long ig7 long product primer set was used and for all other 
genes, the short product primer set w'as used. For all primer details and validation see 
appendix.
2.21 Immunofluorescence
For immunofluorescence imaging, cells were seeded onto poly-L-lysine coated 
coverslips, and allowed to adhere for 30 minutes. Coverslips were then washed twice 
in PBS and fixed in 3% paraformaldehyde (in PBS) for 20 minutes. They were then 
washed three times more and permeabilised by two incubations of 15 minutes in 1%
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gelatin/ 0.2% saponin. Cells were then stained with M2-mouse a-FLAG primary 
antibody (1:1,000 dilution Sigma) for one hour, washed three times, and then a FITC- 
conjugated a-mouse IgG secondary antibody (1:1,000, Sigma) mixed with 1 pg/ml 
4\6-Diamidino-2-phenylindole dihydrochloride (DAPI). Coverslips were then 
washed and mounted on slides using Vectorshield mounting medium (Vector Labs). 
Images were then taken using a 40x oil immersion objective on a Leica TCS SP2 
confocal microscope.
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Chapter 3:
Multiple Inositol Polyphosphate phosphatase activity 
is required for lithium resistance in PO null cells
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3.1 Introduction
In Dictyostelium , a genetic screen for cells resistant to the effects of lithium on 
aggregation identified the enzyme prolyl oligopeptidase (PO). In this system, cells 
lacking all PO activity were able to aggregate at concentrations of lithium where wild- 
type cells cannot -  albeit with an altered morphology, probably due to inhibition of 
GskA (Williams et al., 1999).
In these cells, it was also noted that disruption of the PO gene leads to increased 
Ins(1.4.5)P3 levels due to increased Ins(1.3,4,5.6)P5 dephosphorylation, and this 
inositol phosphatase activity is also inhibited in PO overexpressing cells ((Williams et 
al., 1999) and R. Williams, unpublished data). In astroglioma cells, a similar effect 
has also been observed, were treatment with a PO specific inhibitor led to increased 
Ins(l,4.5)P3 levels, although in this study the mechanism was not investigated (Schulz 
et al.. 2002).
This phosphatase activity was previously identified in Dictyostelium as an alternative 
route ofIns(l,4 ,5)P3 production in cells lacking phospholipase C activity (Van Dijken 
et al., 1997), and when purified from mammalian sources it was shown that the 
multiple dephosphorylations are catalysed by a single enzyme, Multiple Inositol 
Polyphosphate Phosphatase (MIPP) (Craxton et al., 1995; Nogimori et al., 1991; Van 
Dijken et ah. 1995a). Therefore, in Dictyostelium because o f the ability to directly 
phosphorylate inositol to form InsPa, Ins(l,4,5)P3 levels can be maintained and 
regulated completely independently of PLC.
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MIPP is therefore a likely candidate as the target of PO which gives lithium resistance 
(implicating an inositol depletion mechanism) and therefore I have identified, cloned 
and disrupted the Dictyostelium  homologue of MIPP in order to test this hypothesis.
3.2 Identification of Dictyostelium MIPP
The first MIPP to be cloned was from rat liver and was found to contain the catalytic 
motif of the histidine acid phosphatase family (RHGXRXP), distinct from all other 
known inositol phosphatases (Craxton et al., 1997). When this was cloned the only 
protein in the animal kingdom found to share homology throughout its length was a 
partly characterized protein from chick chondrocytes, up regulated when these cells 
become hypertrophic, HiPER, sharing 64% homology (Reynolds et al., 1996) an 
effect later observed with rat MIPP (Caffrey et al., 1999). This motif is closely 
conserved throughout evolution, including the fungal InsPe phosphatase phytase. 
although in these enzymes the homology is restricted to this region.
The motif conserved in MIPP and phytase was used to screen the complete 
Dictyostelium genome using a BLAST search in order to identify potential 
homologues. The search gave only two good candidates - predicted proteins DDB 
0186447 and DDB 0218876 hereafter named MippA and MippB respectively 
(encoded by the genes mppA and mppB). Both genes are located on chromosome 4 
(although in distinct regions, co-ordinates 3103340-3105247 and 5169198-5170721 
respectively) and consist o f a single exon, but neither has any EST data indicating 
expression (from www.dictybase.org). The two predicted protein products are closely
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related to each other, sharing 70% sequence identity although MippA has an extended 
C-terminus and therefore they may serve different biological functions (see Fig. 3.1).
When compared to other species, both Dictyostelium genes share conserved residues 
with other eukaryotic MIPPs along their length whilst differing significantly from the 
fungal phytase gene except in the active site (Fig. 3.2).
3.3 The expression of MIPP in Dictyostelium
To examine expression, specific primers were designed for mppA and mppB and 
expression tested by RT-PCR on a cDNA library constructed from vegetative cells. In 
this assay, only the mppA primers gave a product, although as a control both products 
could be amplified from a genomic DNA template (Fig. 3.3). This indicates that 
mppB is not expressed in vegetative cells.
To test whether either gene was developmentally regulated, expression at different 
times post-starvation was analysed by quantitative real time PCR (Q-RT PCR). At all 
time points, and over two independent experiments, no mppB expression could be 
detected. In contrast mppA expression remained fairly constant, although it may drop 
slightly after 4 hours (Fig. 3.3). In addition the copy number of mppA mRNA in 
vegetative cells was measured (by Q-RT PCR) and it was found to be present at only 
3 copies per cell (see appendix), indicating that the protein may have a slow turnover, 
and possibly explaining why no ESTs have been found.
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Figure. 3.1: Sequence and alignment of Dictyostelium  M IPP homologues. The
boxed region represents the conserved catalytic motif.
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Figure 3.2: Alignment of M IPP genes across evolution. The boxed region 
represents the conserved catalytic motif.
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Figure 3.3. The expression of Dictyostelium  MIPP homologues. (A) RT-PCR analysis o f mppA and 
mppB in vegetative cells. Second panel indicates a control reaction using a genomic DNA template with 
the mppB primer set. (B) Developmental expression o f mippA relative to vegetative (Ohrs) cells. Samples 
were measured using quantitative real time PCR, two independent experiments are plotted.
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3.4 Generation of a mppA knockout
In order to study the effect of MIPP activity on lithium resistance a strain with a 
disrupted mppA gene was generated. This was done by homologous recombination, 
leading to the insertion of a blasticidin selectable marker cassette (flanked by cre- 
recombinase sites (Faix et al., 2004)) into the single genomic copy. Clones were 
originally screened by PCR and then confirmed by southern blot (Fig. 3.4). When a 
knockout was isolated, expression of both MIPP genes was once again tested by RT- 
PCR and no expression of mppA, nor any compensatory up-regulation oim ppB  could 
be detected (Fig. 3.4).
3.5 Overexpression of mppA
In addition to a knockout, we also wanted to produce an overexpressor of mppA. All 
the MIPP enzymes so far studied, including the InsPs phosphatase activity in 
Dictyostelium are found in the insoluble fraction of extracts, and the native enzyme 
has been isolated from the 100,000g particulate fraction of cell extracts (Craxton et 
al., 1995: Van Dijken et al., 1995a). This is thought to be due to insertion of the N- 
terminus into a membrane, a truncation of which results in a soluble form of the rat 
enzyme which is then mis-localised to the cytoplasm and can result in elevated basal 
calcium levels (Craxton et al., 1997; Yu et al., 2003). In addition, the C-terminus of 
the human, rat and chick proteins contain putative XDEL motifs which is a signature 
for proteins found within the ER. Therefore addition of a tag to either end is
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problematic, and indeed when I made constructs adding an epitope tag to either end, 
or even to an N-terminal truncated version of MippA they were not expressed in 
Dictyostelium and were either not expressed, or completely insoluble in E. coli (data 
not shown).
A construct expressing an untagged, full-length MippA under the control of the 
constitutively active actin 15 promoter was made. When this was transformed into 
cells, MIPP activity (as measured by Ins(l,4,5)P3 production from InsP6 in the 
particulate fraction) was increased by approximately 100 fold. As previously reported, 
this activity is also moderately increased in PO null cells but is completely absent in 
both the soluble, or particulate fractions o f the mppA null mutants described above 
(Fig. 3.5). We therefore conclude that mppA encodes a functional MIPP enzyme and 
is indeed the only functional enzyme that we can detect in growing, or developing 
cells.
3.6 The biochemistry of Dictyostelium MIPP
To further understand the role of MippA within the cell, its biochemistry was 
analysed using the MDD-HPLC system, which is able to directly detect and resolve 
many of the inositol polyphosphate isomers. In crude particulate extracts from MippA 
overexpressing cells there appear to be two inositol phosphatase activites present: 
firstly MIPP activity, degrading InsP6 and producing a peak of InsP3 , which is 
abolished in the knockout; and secondly, a MippA-independent 5’ phosphatase 
activity which degrades Ins(l,4,5)P3 to a single peak co-eluting with an authentic 
Ins(l,4)P2 standard (Fig. 3.6 B and C).
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Figure 3.4: Generation of a mippA null strain. (A) Schematic o f the knockout construct transformed into 
cells. (B) Southern blot o f a wild-type and mippA' cells after digestion with Spel/Clal. (C) RT-PCR analysis 
of mppA/B expression in vegetative, mppA' cells. (D) Control PCR using the same primer sets with a mppA' 
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Figure 3.5: MIPP activity in mutant cells. (A) The 100,000g particulate fraction from wild- 
type, dpoA\ mppA' and mppA overexpressing cell extracts were incubated with 0.1 mM InsP6 and 
lns(l,4,5)P3 formation measured at the times indicated. Values are normalised to protein content 
and are from a typical experiment. (B) Cell extracts from wild-type and mppA' cells were spun at 
100,000g and both pellet and supernatant fractions incubated for 30mins before InsP3 
determinations. Activity is measured by accumulation o f Ins(l,4,5)P3, subtracting the starting 
concentration. Negative activity is due to both noise within the assay as well as the degradation 
of!ns(l,4 ,5 )P3 by contaminating 5’ phosphatases.
66
m ppA  I h r
10
m p p A  Ohrs
0. 5 m ppA  o /e  1 hr
m p p A  o /e  Ohrs0 0
c
3 0 0  -
2 0 0  -
1 on -
>e
- 2 0 0  -
m -
- 4 0 0
3 M in u te s
B
m ppA  1 hr
m ppA ' Ohrs
0 50  -
m ppA  o /e  1 hr
m ppA  o /e  Ohrs
M in u te s
D
m ppA ' l h r
m ppA ' Ohrs
i 0
m ppA  o /e  l h rU S
m ppA  o /e  Ohrsu u
0 2 35
Mi r i j te  i.
Figure 3.6: Analysis of MIPP substrate specificity. The insoluble fractions from either mppA null or 
overexpressing cells were incubated with either (A) 10 nmoles InsP6 (B) 10 nmoles Ins(l,4,5)P3 or (D) 10 
nmoles 2.3-diphosphoglycerate. Samples were removed at the start and after 1 hour as indicated. (C) Shows 
the product of Ins( 1,4,5)P3 dephosphorylation (top trace) compared with authentic Ins(l,4)P2 and Ins(4,5)P2 
standards. In all traces the y-axis refers to the bottom trace and the other traces have been offset for clarity.
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In addition to inositol polyphosphates, it has also been suggested that MIPP may also 
be able to use 2,3 diphosphoglycerate (DPG), a glycolytic intermediate as a substrate 
(S. Shears, personal communication). When incubated with Dictyostelium  extracts 
from mppA overexpressing cells, DPG was rapidly converted to an undetectable 
species presumably by dephosphorylation (note that in our system, detection is based 
on phosphate content). However in mppA' extracts DPG was stable, indicating that 
this is a MippA specific activity (Fig. 3.6). This is interesting because DPG is also a 
potent inhibitor of inositol 5’phosphatase activity (Downes et al.. 1982), and therefore 
in conditions where MIPP activity is elevated such as in dpoA' mutants, this 
5'phosphatase inhibition may be reduced, allowing the coordinate regulation of both 
enzymes involved in the conversion of InsP6  to InsP2 .
In our assay, when extracts from mppA overexpressing cells are incubated with 
0.1 mM InsP6 . the InsPe is rapidly hydrolysed and only a single peak of InsP3 
production is detected (presumably Ins(l,4 ,5 )P3 which is then in turn hydrolysed by 
the 5'phosphatase). To our surprise we also observed that when a higher 
concentration o f InsP6 was used, a dramatically different chromatogram was obtained. 
If MIPP is incubated with ImM InsP6 . it is hydrolysed at either the 3’, 5' or 6 ' 
positions, to give InsPs and InsP4  isomers which were not previously seen and do not 
co-elute with the Ins(l,4 ,5 ,6 )P4 or Ins(1 .3 ,4 ,5 )P4 intermediates which would be 
expected by the normal reaction. These are then further resolved into a single InsP3 
peak. This i> not further degraded to Ins(l,4 )P2 indicating that it is a poor substrate for 
the 5’phosphatase (Fig. 3.7).
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This observation indicates that, at high concentrations o f InsP6  the enzyme does not 
attack the T  position, instead removing alternative phosphate groups. If these 
phosphoinositides were poor substrates for sequential dephosphorylation they would 
accumulate slightly. Indeed if this were the case and MIPP only removes the 3’, 5’ 
and 6 ' phosphates (as is indicated by the InsPs isomers formed) this would result in 
the formation of In s(l,2 ,4 )P3 which would not be a substrate for a 5’ phosphatase.
To date no 2' phosphorylated inositides have been found to be biologically active and 
do not appear to be present in most biological systems. In addition, the reaction 
observed at lower InsP6 concentrations is much more efficient with no intermediates 
at all accumulating between InsP6 and InsP3 . 1  suggest that this is more likely to be the 
more physiological reaction.
3.7 The effect of MIPP mutants on inositol metabolism
To assess what role MippA plays in vivo the intracellular inositol phosphates in both 
null and overexpressor cell lines were quantified by HPLC (Figs. 3.8, 3.9 and table 
3.1). I detected no significant difference in the relative abundance o f any 
phosphoinositide species in the mppA null cells, compared to wild-type. The 
overexpressors however show an increase in all the inositol phosphates generated in 
the reaction described above at high InsPft concentrations, although many of the other 
species (including InsP6 ) remain constant.
This is perhaps not surprising as the intracellular concentration of InsP6 is estimated 
as '-ImM  in Dictyostelium (Martin et al., 1987) and therefore indicates that in MippA
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overexpressing cells at least, it is present in a compartment with high InsP6 levels. 
This however may well be misleading as these cells have a -1 0 0  fold increase in 
activity compared to wild-type and therefore some enzyme may be mis-localised, or 
leaked into the wrong compartment. It is also of note though, that in these cells there 
is no detectable In s(l,3 ,4 ,5 ,6 )P5 (normally present at 44 pmol/107 cells), the normal 
precursor of Ins(l,4 ,5 )P3 production by MIPP and therefore it appears that both 
reactions are occurring simultaneously although perhaps not in the same place.
When intracellular Ins(1 .4 ,5 )P3 levels are measured by the isotope dilution method no 
significant difference could be detected between either mppA null or overexpressing 
cells and wild-type (Fig. 3.8). This assay uses an Ins(l,4 ,5 )P 3 -binding protein for 
detection and therefore should be specific for this isomer. In HPLC analysis o f mppA 
overexpressing cells however, a large accumulation of InsP3 is seen and therefore this 
must consist o f an alternative isomer, most likely Ins(l,2 ,4 )P3 .
3.8 Generation of dpoA/mppA double mutants
In order to test whether the lithium resistance phenotype see in PO null cells is due to 
increased MippA activity, a double mutant was generated and lithium sensitivity 
examined. In isolating the original mppA knockout, a cre-lox flanked blasticidin gene 
was used, therefore these cells were transformed with a cre-recombinase expression 
construct to allow a sequential knockout to be generated using the same selectable 
marker (Faix et ah, 2004).
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Fig. 3.7: Hydrolysis of InsP6 by MippA. The particulate fraction of cell extracts from MippA 
overexpressing cells were incubated with InsP6  at either (A) 0.1 mM or (B) ImM. Samples containing 
the equivalent of lOnmol of initial InsP6  were removed at the times indicated, and analysed by HPLC. 
Peaks were identified as a -  Ins(l,4 )P2 ; b -  InsP3 isomers; c - InsP6 ; d -  InsP4  isomers; e -  
Inst 1.2.3,4.6 )P.s f -  Ins(l,2 ,3 ,4 ,5 )P5 ; g -  Ins(l,2 ,4 ,5 ,6 )P5 . Again, the Y-axis refers to the bottom trace 
and the other traces are offset for clarity.
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Figure 3.8: Analysis of inositol phosphate abundance in mppA  mutants. Cells extracts were
prepared and analysed by (A) HPLC-MDD, and (B) the Ins(l,4 ,5 )P 3 -  specific isotope dilution assay.
Isomers separated by HPLC were identified as: a -  unresolved InsP3 isomers; b -
Ins( 1 ,2,3,5)/( 1 ,2,4,6)P4; c  -  Ins(l,2,4,5)P4; d -  Ins(l,2,5,6)P4; e -  Ins(l,4,5,6)P4; f -  Ins(l,2,3,4,6)P5; g
-Ins(l,2 ,3 ,4 ,5 )P5; h - I n s ( l ,2,4,5,6 )P5; i - I n s ( l , 3,4,6 )/( l,2,3,4)P4; j  -  Ins (2,4,5,6)P4; k-
Ins(l,3,4,5,6)P5.
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Figure 3.9: Relative distribution of the higher order inositol phosphates. Inositol phosphate 
abundance was determined by HPLC for each strain and normalised to total inositol polyphosphate 
levels. Values plotted are the means ± standard deviation of at least 3 independent experiments.
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P m o l  / 107 cel ls
Wild-ty pe dpoA'
lnsP3 0 0
Ins( 1235/1246 )P4* 1 1
lns( 1346,1234 )P4* 21 16
Ins( 1245 )P4* 0 0
lns(1345)P, 0 0
Ins(1256)P4* 23 23
In s(2 4 5 6 )P / 10 9
Ins( 1456 )P4 0 2
lns(12346)I \ 52 41
Ins( 12345 )Ps* 0 1
Ins(12456)P f 236 210
lns( 134 56 )Ps 44 33
lnsP6 637 472
InsP-7” 71 56
InsPs*' 88 46
Total 1181 901
m p p A '
m ppA ' /d poA ' mppA  o/e
0 0 208
0 1 17
15 15 10
0 0 182
0 0 0
13 31 75
5 14 12
0 0 13
51 29 66
0 0 151
226 178 332
46 40 15
773 422 523
75 53 58
90 48 99
1293 831 1761
Table 3.1: Inositol phosphate abundance in mutant cells. Cell extracts were 
prepared and analysed by HPLC to quantify inositol phosphate abundance. Where 
indicated, isomers could not be separated. Inositol phosphates marked * are not 
commercially available and therefore a standard curve was estimated from other 
similar isomers. Compounds marked ** are also unavailable but also have no 
available isomers. Therefore in these cases a standard curve was estimated from InsP6 
values corrected for phosphate content. All values are the mean o f at least 3 
independent determinations.
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After transformation with this vector and re-cloning -70%  of clones were blasticidin 
sensitive. Recombination was then screened by PCR amplification of the genomic 
locus, and showed that specific recombination had occurred in all blasticidin sensitive 
clones to remove the gene, giving a PCR product slightly larger than that of the wild- 
type gene due to the insertion of multiple stop codons (Fig. 3.10). Loss o f MIPP was 
confirmed by MIPP assay.
To generate a double mutant these cells were then transformed with the plasmid 
HAD 172, used to recapitulate the PO mutant in the original study (Williams et al., 
1999). Independent clones were screened by enzyme assay for loss o f PO activity and 
many double mutants isolated (Fig. 3.10). As MIPP activity is increase by the loss of 
PO. it is possible that the converse may be true. However, when PO activity was 
measured in mppA mutant cells, no reciprocal change in activity was seen (Fig. 3.10).
3.9 Inositide abundance in dpoA/mppA mutants
dpoA null cells have elevated MIPP activity, and therefore changes in the abundance 
of higher inositol phosphate species might be expected. However when this was 
measured by HPLC, no significant changes were detected between either dpoA and 
mppA single and double mutants, when compared to wild-type (Table 3.1 and Fig. 
3.9).
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3.10 The effect of lithium on cell movement
In our standard assay for lithium resistance, Dictyostelium  mutants are allowed to 
develop on either agar plates or filters and tested for their ability to form fruiting 
bodies in the presence o f lithium. Whilst this approach is excellent for screening large 
numbers of clones, to get a more clear understanding of how lithium blocks 
aggregation and to be able to quantify and compare the sensitivity o f different 
mutants, a more sensitive and detailed study is required. Therefore the effects of 
lithium on cell motility, both on random amoeboid and directed chemotactic 
movement were examined. It should be noted that to correct for any non-specific 
effects cause by salt concentration, all experiments were repeated on the same day in 
the same concentrations of NaCl and LiCl and normalised, where appropriate, to give 
a lithium sensitivity index for each parameter (LSI, defined as value in LiCl / value in 
NaCl).
3.10.1 Random amoeboid movement
To study random cell movement, in the absence of any chemotactic gradient, 
vegetative cells were simply placed in buffer containing different concentrations of 
lithium or sodium chloride, left for one hour and then analysed using time-lapse 
microscopy and image analysis software.
When vegetative wild-type cells were treated in this way, a strong dose-dependant 
inhibition of their motility with lithium was seen (Fig. 3.11). At 5mM LiCl cell speed 
is reduced by 42 ± 3% (P<0.001). In addition, cell turning was slightly affected, with
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Figure 3.10: Generation of a mppA' / dpoA' double mutant. (A) PCR analysis o f the mppA genomic 
locus after cre-recombination. (B) MIPP activity assay o f these cells. (C) PO activity assay of double 
mutants and PO overexpressors. Results are the mean ± standard deviation o f at least 3 independent 
experiments.
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Figure 3.11: Lithium inhibition of cell movement. (A) Vegetative wild-type cells were placed in 
KK2 buffer containing the concentrations o f lithium indicated. Cell movement was then recorded 
over a 10 minute period by time-lapse microscopy. Cell outlines were then determined for each frame 
and the path of each cell plotted, using 2D DIAS software. In addition cell speed was calculated for 
each lithium concentration and plotted in (B). Values are the means ± standard deviation of at least 
50 cells.
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the amount of direction change increasing by 34 ± 10 %, although this is not as 
significant and therefore may be simply an artefact of the cells moving more slowly 
(P = 0.06). As these conditions show a moderate, but not complete inhibition of cell 
movement, they were therefore used in the further analysis as both resistance and 
hypersensitivity to lithium should be apparent.
3.10.2 Chemotaxic movement
During aggregation, Dictyostelium do not move randomly, and therefore the effects of 
lithium on the ability of a cell to respond to, and move up a gradient o f 
chemoattractant were examined. In this case, cells were used w'hich had been starved 
and exposed to pulses of cAMP for 5 hours - with LiCl or NaCl added for the final 
hour. At this stage, cells have begun development, and upregulated the machinery 
required to respond to cAMP but have not yet reached the stage where polarity is 
intransient and therefore represents a point where chemotactic differences should be 
most obvious. The cells were then placed in a Zigmond chamber in a gradient of 
cAMP. and analysed shortly afterwards.
Under these conditions cells are less sensitive to lithium and treatment with 5mM 
LiCl caused no observable defect (R. Teo, unpublished data). Therefore for this assay 
the lithium concentration was increased to 7mM - comparable to the concentration 
required to inhibit aggregation on agar. At this concentration, the speed of wild-type 
cells was reduced by 23 ± 7 % (P<0.005).
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In order to measure how efficiently the cells were moving towards the cAMP source, 
another parameter was calculated, the directionality. This is defined as the net path 
length / total path length, and therefore a cell moving in a straight line would have a 
value of 1 whereas a cell moving in a zig-zag or circle would have a much lower 
value, independent of speed. In this assay, wild-type cells move with a directionality 
= 0.7 ± 0.07 in 7mM NaCl, which is reduced by 14 ± 7% in lithium (P=0.02).
In both random, and directed chemotactic movement it seems that lithium has the 
common effect of inhibiting cell movement. This would clearly lead to a block in 
aggregation as originally observed and therefore we can use this to study and quantify 
how the lithium sensitivity of the mutant strains generated above is affected.
3.11 Analysis of the lithium sensitivity of mutant cells
3.11.1 Random movement
To determine whether MippA is required for the lithium resistance seen in dpoA null 
cells, the lithium sensitivity of both single and double knockout strains was examined 
using the assays described above. In the random movement assay, none of the mutant 
strains differed from wild-type in the absence of lithium. However, in 5mM LiCl, 
dpoA' cells are more resistant than wild-type, moving at 7.3 ± 0.5 pm/min as opposed 
to 6.0 ± 0.5 pm/min (P=0.007). This effect was lost in two independent mppA/dpoA 
double mutant clones which did not differ significantly from wild-type (Fig. 3.12).
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The original hypothesis was that the dpoA' mutant was resistant to lithium due to 
elevated MIPP activity. Unexpectedly I found that mppA overexpressing cells were 
hypersensitive to lithium and were almost stationary, moving at 2.9 ± 0.1 pm/min in 
the presence of 5mM LiCl (P<0.005). I measured a lower value for mppA' cells than 
wild-type although this is not as statistically significant (P=0.01).
3.11.2 Lithium sensitivity during chemotaxis
When these strains were examined in a cAMP gradient, similar results were obtained. 
Again, in the presence of 7mM NaCl control, all cell lines were indistinguishable, and 
the differences only became apparent after lithium treatment. Results were normalized 
to a NaCl control on the same day to account for day-to-day variation (raw values for 
the average speed and chemotactic index are included in appendix II).
In this assay, dpoA' cells again had reduced lithium sensitivity compared to wild type, 
with speed reduced to 8 8  ± 13% compared to 77 ± 7% and although the statistical 
significance of this was slightly above P=0.05 they are also more resistant than dpoA' 
mppA' double mutants (P=0.01) (Fig. 3.13). Again, mppA overexpressors were more 
sensitive than wild-type (P=0.01), unlike mppA' cells which were indistinguishable 
from wild-type. As well as speed, the directionality for these cells was also calculated. 
In each cell line, this was affected to a similar degree to speed and therefore the two 
appear to be intimately linked, at least in their lithium sensitivity (fig.3.13).
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5m M  NaCl 
5m M  LiCl
* * ♦
Wild-type dpoA- mppA- mppA- 
/dpoA-1
mppA- mppA o/e 
/dpoA-2
Figure 3.12: Sensitivity of random movement to lithium in mutant strains. Mutant strains 
were grown vegetatively and treated with either 5mM LiCl or NaCl for one hour. Their 
movement was then analysed and average speed calculated. Values plotted are the mean ± 
standard deviation of at least 4 independent experiments, minimum of 50 cells per experiment.** 
- P<0.01, *** - P<0.005, Students T-test compared to wild-type.
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Figure 3.13: Lithium sensitivity in chemotaxing cells. Cells were pulsed for 5 hours with either 
7mM LiCl or NaCl added for the final hour. They were then placed in a static cAMP gradient and 
their movement analysed. Each experiment was normalised to a NaCl control done on the same day 
to give a lithium sensitivity index (LSI). Results plotted are the means ± standard deviation of four 
independent experiments with at least 50 cells measured each time. * P<0.06, ** P<0.01, *** 
P<0.005; Student T-test compared to wild-type.
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3.12 Discussion
3.12.1 Dictyostelium MIPP
From this work we can conclude that although the Dictyostelium  genome contains 
two clear MIPP homologues, a single gene is responsible for all activity observed in 
both vegetative, and developing cells. Why a second gene is present which does not 
seem to be expressed is interesting, and although we have not shown mppB to encode 
an active phosphatase, it has preserved all the residues which are conserved 
throughout evolution and are likely to be important for function, whilst being 
significantly different from MippA in both protein and nucleotide sequence, 
suggesting a similar activity, but a divergent role. The fact that this gene has been 
retained indicates that it plays an important role -  presumably in an alternative 
process such as during the sexual cycle.
In mppA knockout cells, no InsP6 or Ins(l,3 ,4 ,5 ,6 )P5 hydrolysis could be detected, 
either in the soluble, or particulate fractions and therefore we conclude that this gene 
is responsible for the activity described by both Drayer et al. in pic  cells, and 
Williams et al. in dpoA' cells (Drayer et al., 1994; Williams et al., 1999).
3.11.2 The activity of Dictyostelium MIPP
The original biochemical characterization of MIPP activity in Dictyostelium indicated 
that only Ins(l,3 ,4 ,5 ,6 )P 5 and In s(l,3 ,4 ,5 )P4  / In s(l,4 ,5 ,6 )P4  were substrates for
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Ins(l,4 ,5 )P3 production and that InsP6  was not (Van Dijken et al., 1995a). In this 
study however, I have found that InsP6  is a substrate. This discrepancy may be 
explained by the rather surprising results obtained when different concentrations of 
InsP6 were used as a substrate. As MIPP is able to differentially dephosphorylate 
InsP6 at different concentrations, it may be that in the original assay, excessive 
substrate was used leading to the formation of alternative InsP 3 isomers which would 
not be detected in their assay.
Although it is hard to reconcile the differential dephosphorylation o f InsP6  at high and 
low substrate concentrations with an enzymatic mechanism, previous studies have 
also hinted at similar peculiarities. Initially MIPP was identified as an In s(l,3 ,4 ,5 )P4 
3' -phosphatase, and InsP6  was considered a ‘‘potent endogenous inhibitor” as well as 
a substrate (Hodgson and Shears, 1990; Hughes and Shears, 1990). In a study by 
Nogimori et al., they show that InsP6  binds the mammalian enzyme with a very high 
affinity (Km= 0.3nM) but with a Vmax of about 350-fold lower than when 
Ins(1 .3 ,4 ,5 )P4 is the substrate (Km =130nM). Therefore they propose a mechanism 
where InsP6 is a strong competitive inhibitor, whilst being a poor substrate (Nogimori 
et al., 1991). Interestingly, they also observe a very similar pattern of InsP6  
dephosphorylation to that seen in this study at high InsP6 concentrations and conclude 
that it is a non-specific phosphatase when InsP6  is the substrate. My study would 
indicate that this is not the case, and that InsP6  is actually a good substrate but only at 
a certain concentrations.
Biochemically it is hard to understand how this mechanism would work and it seems 
to be without precedent. It may indicate a second low affinity, InsP6 binding site, or
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perhaps the ability of InsP6 to bind metal ions can alter the specificity of the reaction. 
Alternatively, it may be that these 2’ phosphorylated inositides are always formed at a 
low rate, and that only in high InsP6  concentrations do they accumulate sufficiently to 
competitively inhibit the normal reaction. To study this further requires purified 
enzyme which we are currently unable to produce.
These observations could have physiological consequences, as they suggest that for 
optimal activity and the production of a biologically active product, MIPP must be 
present in a distinct compartment, away from the high concentrations of InsP6  found 
in the cytosol. In mammalian cells, biochemical studies have placed MIPP activity 
within the ER whereas its substrates are predominantly cytosolic (Ali et al., 1993; 
Romano et al., 1998). In contrast, fractionation studies of Dictyostelium  extracts 
found that this activity exclusively co-elutes with plasma membrane markers, and not 
ER (Van Dijken et al., 1997). This activity was further shown to be on the inside of 
the cell which would mean exposure to the large cytoplasmic phosphoinositide pool.
If this were the case, MIPP would be exposed to the large, high concentration pool of 
lnsP6 and the accumulation of T  phosphorylated inositides would be predicted. In 
vivo the only detectable 2‘phosphorylated species in Dictyostelium  are 
Ins(l,2,3,4,6 )Ps, Ins(l,2 ,3 ,4 ,5 )P5 and In s(l,2 ,5 ,6 )P4 and as these are unaltered in 
mppA' cells they are probably formed as non-specific side-products of a different 
phosphatase due to the exceptionally high InsP6 concentrations. This, and the fact that 
no differences in phosphoinositide abundance, including InsP6 , could be detected in 
the mppA' cells indicate that it uses a distinct, much smaller pool of substrate, which 
we cannot separate from the much larger cytoplasmic one. This however is not the
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case when mppA is strongly overexpressed. In these cells MIPP does not appear to be 
so tightly contained and some of the enzyme is able to utilize the high concentration 
pool, leading to the accumulation of 2 ' phosphorylated species and a complete 
depletion of In s(l,3,4,5,6 )P5 .
The difficulties found in adding an epitope tag to the full-length protein in all 
organisms has prevented a clear understanding of the localization and role of MIPP 
within the cell. We are currently producing an antibody which will tell us more about 
both MIPP and the subcellular distribution of inositol phosphates in vivo.
3.12.3 Inositide abundance in dpoA mutants
In clpoA\ mppA' and double mutant cells, I detected no significant change in 
phosphoinositide levels, including no accumulation of 2 ’phosphorylated species. 
These observations are in agreement with those made in the original pic- mutant, 
which also had elevated MIPP activity but no major change in phosphoinositide 
abundance (Drayer et al., 1994) and would indicate that the more subtle increase in 
MIPP activity in these cells does not significantly alter the metabolism of the majority 
of the inositol phosphates. Therefore again it is likely that only a small subset of the 
phosphoinositides are affected which we cannot detect. Indeed, in order to efficiently 
produce a change, any signaling molecule is required to be at low abundance and 
therefore in this case, HPLC analysis may not be sensitive enough to detect these 
changes.
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3.12.4 MippA activity is required for lithium resistance
Whether in an assay for random or directed chemotactic movement, lithium has the 
effect of reducing the cell speed. In tandem, the amount of cell turning is also 
increased, both factors leading to a developmental block at aggregation. Cells lacking 
PO activity are more resistant to these effects, when mppA is also disrupted, this 
resistance is lost. This places mppA genetically downstream of dpoA. This would 
therefore implicate inositol metabolism and therefore inhibition of IMPase and IPP as 
the cause of this reduced motility. This raises the question of how increased MIPP 
activity leads to resistance, and how inhibition of inositol metabolism by lithium leads 
to defective chemotaxis.
Some clarity may be obtained from observations with mppA overexpressing cells. 
Although these cells are no different from wild-type in control experiments, they are 
consistently more strongly affected by lithium. This is in contrast to dpoA' cells which 
also have elevated MIPP activity, but are resistant. The major difference between the 
two cases is the extent to which MIPP activity is increased -  in dpoA mutants, it is 
elevated by about 1.5 fold compared to -100 fold in the mppA overexpressor. This 
indicates that elevating InsP3 synthesis from of InsP6 dephosphorylation is not 
sufficient for lithium resistance, and that other factors are also involved. As we have 
seen, the mppA overexpressor has enormous activity - some of which appears to be 
mis-localised; this may mean that pools of inositol phosphates, not normally regulated 
by MIPP are altered and could explain the difference between the effects of small and 
large increases in activity.
Although these experiments show a clear link between PO, MIPP and lithium 
sensitivity, and is in fact the first mechanism of MIPP regulation to be identified, how 
PO is able to regulate MIPP is unknown, and as the crystal structure of PO is thought 
to preclude the use of proteins as a substrate (Hiramatsu et al., 2003), this relationship 
is likely to be indirect. The fact that alterations in MIPP activity can be shown to alter 
lithium sensitivity does however represent a novel mechanism by which MIPP and 
the higher order inositol phosphates can regulate cellular behaviour.
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Chapter 4:
Higher inositol phosphates regulate lithium sensitivity 
through gene expression in Dictyostelium
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4.1 Introduction
In the previous chapter I showed that MippA activity is required to mediate the effects 
of PO loss on lithium resistance to chemotaxis. This implies that alteration in the 
metabolism of higher inositol phosphates is sufficient to give lithium resistance. One 
explanation could be that by elevating the production of Ins(l,4,5)P3 from InsP6, the 
inositol depletion effects of lithium treatment can be overcome. However, although 
this may be able to contribute to a lithium resistant phenotype, it cannot explain why 
cells overexpressing mppA become hypersensitive. In addition, if  the disruption of 
chemotaxis is due to the inhibition of IMPase and IPP, this has been shown to be 
through a non-competitive mechanism as lithium binds the enzyme-substrate complex 
(Gee et al., 1988). This means that increased substrate concentration will not be able 
overcome this, and may actually lead to the inhibition of more enzyme. The only 
method of overcoming this form of inhibition is therefore to increase the enzyme 
concentration.
In yeast, the regulation of gene expression by inositol phosphates has been 
demonstrated a number of times, through a number of mechanisms. These including 
the direct use of inositol kinases (IPK2/Arg82/IPMK) as transcription factors, 
regulation of lipid biosynthesis by the Opilp/Ino2p/Ino4p complex (Hirsch and 
Henry. 1986). the binding of inositol polyphosphates to chromatin remodelling factors 
(Odom et al.. 2000; Shen et al., 2003; Steger et al., 2003) and the regulation of RNA 
export and processing (York et al., 1999) - all o f which could potentially lead to 
increased protein levels. Although we do not know whether MippA is present in the 
nucleus, or is indirectly able to alter the nuclear pool of inositides, it is the only
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known enzyme able to dephosphorylate InsP6 and therefore is potentially able to 
regulate a number of these processes. In this chapter, I investigate whether MippA 
and other inositol metabolic mutants are able to regulate gene expression by similar 
processes, and therefore represent a novel mechanism by which lithium sensitivity 
and chemotaxis may be regulated by the higher order inositol phosphates.
4.2 Identification of Dictyostelium IMPase-family genes
Previously, biochemical study has identified three inositol monophosphatase activities 
in Dictyostelium , two of which are lithium sensitive and therefore o f the IMPase class. 
(Van Dijken et al., 1996a). A BLAST search of the Dictyostelium  genome identified 
3 genes containing the conserved domains of the IMPase family o f proteins (Fig. 4.1). 
Of these, one (im pal, DDB0204100) is more similar to the IMPase proteins of other 
organisms, and work by others in this laboratory has shown that it does indeed encode 
an enzyme with IMPase activity (Keim-Reder, 2006). The other two genes 
(DDBO167248 and DDBO189923) are respectively more similar to the IPP and PAP- 
phosphatase proteins and are designated ippA and B. In other species, however these 
proteins have been shown to have significant activity against more than one class of 
substrate and so to some extent these assignments may be arbitrary (Lopez-Coronado 
et al., 1999).
4.3 Inhibition of PO increases the expression of lithium-sensitive genes
Previous studies have shown that the yeast inol gene, encoding inositol synthase, is 
upregulated upon inositol starvation (Hirsch and Henry, 1986) and can be regulated
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by both the Ino2p/Ino4p complex and several phosphoinositide-sensitive chromatin 
remodeling complexes (Shen et al., 2003). The Dictyostelium  genome contains a 
single homologue, disruption of which leads to inositol auxotrophy and is therefore a 
possible target for regulation (Fischbach et al., 2006).
When Dictyostelium cells were grown overnight with 1.2mM of a PO-specific 
inhibitor z-Pro-L-prolinal (Goossens et al., 1997; Williams et al., 1999), the 
expression of inol was increased by 43 ± 6 %. In addition, the expression of all three 
IMPase family genes was elevated by 60-80% (Fig. 4.2). In contrast, other genes 
involved in the metabolism of the higher order inositol phosphates (see later) 
including mppA were unchanged, showing that these changes are specific, and that 
regulation of MIPP activity is at a post-transcriptional level (for the validation of all 
primer sets used for Q-RT PCR see appendix I).
4.4 MIPP activity is required for regulation of gene expression
To see whether the changes in expression observed above are due to increased MippA 
activity mppA null cells were treated with Z-pro-L-prolinal. When the level of inol 
and impal expression in untreated mppA' cells was compared with wild-type, no 
significant differences were seen and therefore loss o f MIPP does not seem to affect 
expression under normal conditions (Fig. 4.3). However, when these cells were 
treated with PO inhibitor, the increase in inol and impal expression observed in wild- 
type cells was completely blocked showing that MIPP activity is essential for the up- 
regulation of gene expression by PO.
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Figure 4.1: Alignment of Dictyostelium  IMPase family genes against other species.
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Figure 4.2: The effects of PO inhibition on gene expression. Wild-type cells were grown 
overnight in the presence of either 1.2mM z-pro-l-prolinal, or an equivalent volume o f the 
DMSO solvent used. RNA levels were then quantified by real-time PCR, and calculated 
relative to the carrier control. All samples were normalized to Ig7 as a loading control, and 
values shown are the means o f three independent samples. Error bars indicate standard error.
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Figure 4.3 : Gene expression in mppA' cells. (A) Expression of inol and impAl in vegetative 
mppA' cells relative to wild-type. (B) Gene expression of wild-type and mppA' cells treated with 
1.2mM Z-Pro-L-Prolinal relative to the same cells treated with the DMSO carrier. All results are 
the mean ± standard error of at least 3 independent experiments.
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Figure 4.4: Gene expression in mppA overexpressing cells. The expression levels o f in o l , im pAl, 
and ipk.il relative to wild-type were quantified by Q-RT PCR. Results are the mean ± standard error o f 
three independent experiments.
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This suggests a model where the PO-mediated elevation of MIPP activity leads to 
increased expression of impal and lithium resistance, and therefore the expression of 
these genes in mppA overexpressing cells was measured. In these cells, impal 
expression was reduced by 50 ± 14 % when compared to wild-type and explains why 
these cells are also lithium hypersensitive (Fig. 4.4). inol expression was unaffected 
in the mppA overexpressor, indicating that although the two genes may share some 
regulatory elements, they are not identical and are not always co-ordinately changed; 
indeed, in yeast inol expression is regulated in a complex manner by a number of 
factors, some of which may not also regulate impal (Shirra et al., 2005).
4.5 Identification of Dictyostelium Inositol polyphosphate kinases
The data above has shown that MIPP activity is able to change the expression of 
several genes. In order to see whether this is specific to this enzyme or due to a more 
general mechanism of regulation by inositides, other genes involved in the 
metabolism of the higher order inositol phosphates were identified to see if they could 
also induce similar transcriptional changes.
In other organisms, there are two distinct families of enzymes which are able to 
phosphorylate inositides to produce InsP.v These are the IPMK enzymes (known as 
IPK2/arg82 in yeast and are also transcription factors) which typically phosphorylate 
Ins(l,4,5)P. at the 3’ and 6’ positions, and the Ins(l,3,4)P3 576’ kinases which 
phosphorylate Ins(l,3,4)P3 at the 5’ and 6' positions as well as Ins(3,4,5,6)P4 at the 1’ 
position (Odom et al., 2000; Stevenson-Paulik et al., 2002; Verbsky et al., 2005b).
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The end-product of both enzymes is, however the production o f Ins(l,3,4,5,6)P5 
which is subsequently phosphorylated by 2 ’ kinase to produce InsP6.
4.5.1 The Dictyostelium IPMK genes
The IPMK family of enzymes is typified by a tightly conserved PxxxDxKxG 
phosphoinositide binding motif. A search of the Dictyostelium genome identified 
three genes containing this motif -  one of which was the previously identified InsP6 
kinase (Luo et al., 2003).The two other genes (DDB 0203614 and DDB 0218526) 
were named ipkAl and A2 respectively. In addition a third gene was identified (DDB 
0204639. ipkA3), which has -30%  identity to the others along its length, but has the 
proline residue o f the inositide-binding domain replaced with an alanine (which was 
confirmed by sequencing). This residue is absolutely conserved in all other species, 
and therefore this Dictyostelium homologue may either be inactive, or have a different 
substrate specificity. All three genes do however contain the ATP-binding domain 
and other regions previously identified as conserved in this class of enzymes 
(Nalaskowski et al., 2002). All three also lack the calmodulin binding domain which 
distinguishes the specialized subclass of Ins(l,4,5)P3 3’ kinases found in higher 
eukaryotes. (Fig. 4.5) (Nalaskowski et al., 2002; Odom et al., 2000). Therefore we 
conclude that, with the possible exception of the third gene, these encode IPMK 
homologues and when tested by RT-PCR, all three are expressed in vegetative cells 
(Fig. 4.6).
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Figure 4.5: Alignment of Dictyostelium IPMK genes. The three putative Dictyostelium homologues 
were aligned with those identified from other specied. The boxed motif I indicates the conserved 
catalytic motif as are the other characteristic motifs II (unknown function) and III (ATP-binding).
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Figure 4.6: Expression of inositol polvkinases. (A) The expression o f all three IPMK genes and the 
single Ins(l,3,4)P3 5/6 kinase (labelled InsP3 5/6 K) in wild-type cells was verified by RT-PCR of 
vegetative cells. (B) Western blot o f whole cell lysates from cells transformed with kinase 
overexpression constructs. Lysates from cells expressing either tagged Ins(l,3,4)P3 5/6 kinase, or 
IpmkAl were analysed by SDS-PAGE and probed with an anti-FLAG antibody. The control lane is an 
extract from cells transformed with the parent pTX-FLAG vector.
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Figure 4.7: Alignment of Dictyostelium Ins(l,3,4)P3 5/6 kinase with other species. A clustal 
alignment of the single Dictyostelium homologue against those previously identified through 
evolution.
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4.5.2 Dictyostelium  Ins(l,3,4)P3 5/6 kinase
The inositol (1,3,4)P3 5/6 kinase family of enzymes are structurally distinct from 
other inositol kinases and share no significant homology with them. A BLAST search 
of the Dictyostelium genome using the Entamoeba histolytica protein sequence 
yielded a single significant hit (DDB 0190521, here named ipkB). Although no 
signature motifs have been identified for this family of enzymes, when aligned with 
known homologues from other species, the majority of conserved residues were also 
present in the Dictyostelium  gene (Fig. 4.7) (Field et al., 2000; Wilson and Majerus, 
1996; Wilson and Majerus, 1997).
4.6 The generation of Inositol kinase overexpressors
To see whether these genes were able to regulate gene expression, cell lines 
overexpressing a member of each class o f protein were generated. Full-length cDNAs 
of both ipkA 1 and ipkB were cloned into constructs for expression in Dictyostelium , 
under the control of the constitutive actin 15 promoter. In addition, as both proteins 
are soluble, we were able to add a FLAG-epitope tag to the N-terminus o f both and 
after transformation into cells, a protein product of the correct size could be identified 
by western blot (Fig. 4.6).
As I could express tagged fusion proteins in Dictyostelium , I examined their 
subcellular localization. When cells expressing either kinase were fixed and stained, 
both proteins had a predominantly nuclear localization - similar to that reported in
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other organisms and by biochemical studies in Dictyostelium  which placed the 
conversion of Ins(l,4,5)P3 to InsP6 in the nucleus (Van der Kaay et al., 1995). In 
addition, both proteins were also present in numerous small punctate spots throughout 
the cell - which are presumably either vesicles or protein aggregates (Fig. 4.8). 
Whether these spots are real, or an artefact of overexpression is impossible to say 
although such structures have not previously been reported in similar experiments, 
expressing GFP fusion protein in human and Arabidopsis cells (Nalaskowski et al., 
2002; Qin et al., 2005). All other studies with these enzymes have been purely 
biochemical and therefore it may have been missed. Indeed, such a similar pattern for 
both kinases does perhaps suggest that they may be co-localised on vesicles although 
again, it is impossible to tell with these constructs.
4.7 The inositol polyphosphate abundance in inositol kinase overexpressors
In order to assess the effect of inositol kinase overexpression, we extracted the 
inositol phosphates from these cells and quantified them by HPLC-MDD. As with 
many of the other mutants, very little difference between cells overexpressing either 
kinase, and control cells could be detected (Table 4.1 and Fig. 4.9). The only 
significant change seen was that cells overexpressing IpmkAl contained 2.5 fold 
more InsP7 than control (P<0.005, Student’s T-test). Whether this is physiological 
product of the enzyme or not is unclear, but as the enzyme shares a common catalytic 
domain with the InsP6 kinase which would normally synthesise InsP7, it may simply 
be an artefact due to excessively high levels o f expression.
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DAPI a-FLAG
Figure 4.8: The subcellular localisation of IpmkAl and Ins(l,3,4)P3 5/6 kinase. Cells 
overexpressing either IpmkAl (C & D), or In s(l,3 >4 )P3 5/6 kinase (E & F) or control cells transformed 
with pTX-FLAG (A & B) were fixed and stained with stained with both DAPI (A, C and E) and anti- 
FLAG antibody (B, D and F). All images are confocal sections through the middle of the cell. Bar = 
10pm.
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Figure 4.9: Relative distribution of the higher order inositol phosphates in kinase 
overexpressing cells. Inositol phosphate abundance was determined by HPLC for each strain 
and normalised to total inositol polyphosphate levels. Values plotted are the means ± standard 
deviation o f at least 3 independent experiments.
106
Pmol / 1 O' cells
Control
ipkB
o/e
ip kA l
o/e
lnsP3 0 0 0
lns(l 2 3 5 /1 24 6 )P 4‘ 0 0 0
lns(l  346 /12 3 4 ) P f 21 22 14
Ins( 124 5 )P 4* 0 0 0
Ins( 1345 )P4 19 11 15
Ins( 1256 )P4* 13 15 10
Ins(2456)P4* 16 7 6
lns( 145 6 )P 4 0 0 0
Ins( 12 3 4 6 )P ? 43 43 44
Ins( 12345)Ps* 0 0 0
Ins( 12456)Ps* 227 186 193
Ins( 13456)Ps 33 25 32
InsP6 1730 1409 1642
InsP7" 60 42 156
InsPs” 7 13 7
Total 2169 1762 2119
Table 4.1: Inositol phosphate abundance in kinase overexpressing cells. Cell 
extracts were prepared and analysed by HPLC to quantify inositol phosphate 
abundance. Where indicated, isomers could not be separated. Inositol phosphates 
marked * are not commercially available and therefore a standard curve was 
estimated from other similar isomers. Compounds marked ** are also unavailable but 
also have no available isomers. Therefore in these cases a standard curve was 
estimated from InsP6 values corrected for phosphate content. All values are the mean 
of at least 3 independent determinations.
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Figure 4.10: Gene expression in inositol kinase overexpressing cells. The effect o f inositol kinase 
overexpression on the expression o f other inositol metabolic genes was analysed by Q-RT PCR. RNA 
was extracted from cells transformed with either ipkAl or ipkB overexpression constructs and expressioi 
levels calculated relative to cells transformed with the pTX-FLAG parent plasmid. Values plotted are th 
mean ± standard error o f 3 independent experiments.
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To our surprise, overexpression o f neither kinase significantly affected the total 
concentration of Ins(l,3,4,5,6)P5. Others have however reported similar results in 
mammalian cells where overexpression o f IPMK in HEK293 cells also made no 
difference, although Ins(l,3,4)P3 5/6 kinase did increase Ins(l,3,4,5,6)P5 to some 
degree (Verbsky et al., 2005b). In their study, much more dramatic effects were 
observed when the kinases were knocked-down by siRNA, indicating that substrate 
availability is likely to be the limiting factor. Indeed, in our cells neither Ins(l,4,5)P3, 
Ins(l,3,4)P3, Ins(l,4,5.6)P4 nor Ins(3,4.5,6)P4 are detectable by this method and 
therefore this may also be the case in Dictyostelium. Alternatively, it may again be 
that the enzymes can only utilize a small nuclear pool o f phosphoinositides, changes 
of which are obscured by a much larger, cytoplasmic pool. Unfortunately, although 
constructs for both kinases were made, in neither case was I able to isolate knockout 
mutants and therefore they may be essential for survival.
4.8 Gene expression is regulated by inositol kinases
The overexpression o f these two classes o f inositol kinase allows us to test whether 
the changes in inol and im pal expression due to MippA activity are specific, or due 
to a general mechanism o f regulation by inositol phosphates. When the expression of 
these genes in cells overexpressing either kinase were measured, both inol and impal 
RNA levels were increased, by -90%  and 160% respectively (Fig. 4.10). Again this 
seems to be specific to these enzymes, as the kinases do not affect the expression of 
each other, or mppA.
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4.9 Discussion
4.9.1 Loss of PO gives lithium resistance through transcriptional regulation
In our model, inhibition of the IMPase family of proteins by lithium leads to the 
reduced motility described in the previous chapter. Here we show that inhibition of 
proly oligopeptidase leads to a significant increase in the mRNA levels of all three 
IMPase family members. If these increases in mRNA levels are representative of 
changes in protein levels this gives a mechanism for the lithium resistance seen in the 
dPOa null mutant. Indeed, Dictyostelium  cells overexpressing IMPase have been 
shown to become lithium resistant (Keim-Reder, 2006). Also, it is interesting that 
inol is also regulated, as its product, inositol synthase, is an indirect target of valproic 
acid. This would therefore also explain the observation that dpoA null cells are cross- 
resistant to both drugs (Williams et al., 2002).
The changes in gene expression upon PO inhibition are also specific, as it only 
appears to be those genes directly involved in the recycling o f Ins(l,4,5)P3 and de 
novo inositol synthesis that are affected. This argues that the physiological role of this 
response is to adjust the metabolism o f the soluble inositol phosphates feeding into 
phospholipid synthesis. In yeast, inol expression is up-regulated by inositol 
starvation, and 1MN1 (encoding the yeast IMPase) is up-regulated by the addition of 
inositol (I lirsch and Henry, 1986; Murray and Greenberg, 1997; Murray and 
Greenberg, 2000). If this is also the case in Dictyostelium  it may only be necessary for 
the PO to regulate inol expression as this would lead to increased intracellular 
inositol and consequentially the up-regulation of impal -  a hypothesis which may
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now be easily tested using the inol knockout which has recently been isolated 
(Fischbach et al., 2006).
4.9.2 Regulation of gene expression by MippA
When mppA null cells are treated with a PO inhibitor, expression of inol and impal is 
unchanged showing that MippA activity is absolutely required for PO-induced 
changes in gene expression. This explains why the mppA null mutation is a suppressor 
of the cipoA' phenotype. Although we still do not know how PO and MIPP are 
connected, it must be post-transcriptional as mppA expression remains constant 
throughout.
How MIPP alters gene expression in the nucleus is an interesting problem, as all the 
evidence from other organisms places it within the endoplasmic reticulum. Although 
the evidence in Dictyostelium  is inconsistent with this, with MIPP activity co- 
fractionating with plasma membrane markers (Van Dijken et al., 1997), my data in 
this study does indicate that it is restricted within a compartment, away from the bulk 
of its substrates. There is however, no reason to believe that it is in the nucleus (Ali et 
al.. 1993) and thus it would seem that it generates a signal which is transported there. 
Whether this signal is in the form of an inositol phosphate or not is unclear, but as 
InsP6 and inositol kinases are present in the nucleus, if InsP6 is to be metabolized by 
dephosphor} iation it must be able to reach MIPP somehow - again indicating either 
nuclear MIPP or transport between compartments.
I l l
An alternative explanation, may be that MIPP is able to regulate other factors which 
are able to signal to the nucleus. For example, in yeast the membrane lipid 
composition is sensed by O pilp  which is localized to the ER by its association with 
the vesicle-associated-membrane protein-associated protein (VAP) and phosphatidic 
acid (Loewen et al., 2004; Loewen et a l ,  2003); upon addition of inositol, this protein 
is released and translocates to the nucleus to reduce the transcription of U A S ino- 
containing genes, including inol by repression of the Ino2p/Ino4p transcription 
activator complex /Jesch et al., 2005). In addition to this, inositol addition is also able 
to supress the unfolded protein response (UPR) pathway which senses ER secretory 
stress (van Anken and Braakman, 2005), and regulate Ino2p/Ino4p target gene 
expression independently o f O pilp  (Jesch et al., 2006). Therefore, if MIPP is located 
in the ER. it is possible that it is able to regulate either o f these pathways and intersect 
other transcriptional regulators in the nucleus.
Although small increases in MippA activity are able to generate an increase in impal 
expression, a large increase in MippA activity due to overexpression from a strong, 
actin promoter has the opposite effect - correlating with lithium sensitivity. This 
discrepancy could be down to a number o f reasons, most likely due to the mis- 
localisation of the enzyme when strongly overexpressed. One possible reason is that 
the 2 ’ phosphorylated species that accumulate in mppA overexpressing cells are 
potentially competitive substrates for other enzymes involved in inositol metabolism. 
This has previously been shown for Ins(l,2,4)P3 which is able to inhibit the 
Ins(3.4.5,6)P4 Y  kinase activity of the Ins(l,3,4)P3 5/6 kinase enzyme with an I C 5 0  of 
9pM (Adelt et al., 2001). In these cells the concentration o fInsP 3 isomers can be 
estimated as -5 0  pM  (using an average cell volume of 40pm 3, www.dictybase.org)
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and therefore it may actually be this effect, rather than increased MIPP activity which 
leads to the decrease in gene expression. Alternatively in cells overexpressing mppA 
Ins(l,3,4,5,6)P? is completely absent and therefore gene expression may also affected 
by the chromatin remodeling mechanisms described previously.
4.9.3 Transcriptional regulation by the higher inositol phosphates
In addition to MippA, I have shown that the expression o f inol and impal can be 
regulated by two other classes o f enzymes involved in the metabolism of the higher 
order inositol phosphates. This would therefore argue that the effects seen are due to 
changes in inositide abundance rather than any enzyme-specific activity such as the 
regulation of arginine-responsive genes by IPMK/Arg82. Although MIPP is unlikely 
to directly affect nuclear inositides, I have demonstrated that both IpmkAl and 
Ins(1.3,4)P3 5/6 kinase are localized to the nucleus indicating that there is a specific 
nuclear pool and this is therefore likely to be crucial for the regulation of gene 
expression.
With the exception oflnsP?, we were unable to detect any significant changes in 
overall phosphoinositide abundance in the kinase overexpressors. These 
measurements are again most likely hampered by the presence o f a large, reasonably 
static cytoplasmic pool. However, the predicted activities o f these kinases would 
suggest increased rates o f inositol phosphorylation and therefore elevated InsP.s and 
potentially InsPa. As this leads to an increase in expression it would correlate well 
with the chromatin remodeling model suggested by Shen et al. and Steger et al. (Shen 
et al., 2003; Steger et al., 2003), whereby Ins(l,4,5,6)P4 and Ins(l,3,4,5,6)P5 are able
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to activate Svvi/Snf chromatin remodeling complex activity, increasing promoter 
accessibility. An increase in MIPP activity might have a similar effect, as InsP6 was 
also shown to be inhibitory to other chromatin remodeling activities. However, 
without a way of specifically measuring the nuclear inositol phosphates we cannot be 
sure, but this data implies that it may have significance in vivo.
Ultimately, it may be a combination of mechanisms that lead to the observed changes 
in expression, but this study does however demonstrate in vivo that gene expression 
can be regulated by PO via the higher order inositol phosphates. These data also 
directly correlate with the sensitivity to lithium observed in the previous chapter and 
therefore indicates a novel pathway by which both transcription and chemotaxis can 
be regulated by PO, and may have a broad physiological significance.
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Chapter 5:
Lithium inhibits chemotaxis through 
phospholipid depletion
5.1 Introduction
The previous chapters have shown that lithium inhibits cell movement and that this 
may be overcome by increased expression o f the IMPase family of genes in response 
to the loss of PO activity. This indicates that inhibition of movement is due to the 
reduced recycling of Ins(l,4,5)P3 to inositol, which leads to the depletion of both 
inositol phospholipids and Ins(l,4.5)P3 and it may therefore affect the signaling 
properties of both.
As discussed previously, whether calcium signaling plays a direct role in chemotaxis 
is debatable as is the role of Ins(l,4,5)P3. Indeed, Dictyostelium  cells lacking all 
phospholipase C (PLC) activity have no chemotactic defect and develop normally, 
therefore questioning the role of receptor-activated PLC in chemotaxis (Drayer et al., 
1994). In these cells it was also observed that although no Ins(l,4,5)P3 could be 
generated from PtIns(4,5)P2, the intracellular concentration was unchanged due to 
compensatory upregulation of an InsPs phosphatase (Van Dijken et al., 1995a) -  
identified as MippA in this study. As a similar increase in MippA results in lithium 
resistance in dpoA' cells we might therefore expect to see a similar result in pic  cells.
However, PLC is also the only known enzyme which is capable o f hydrolysing 
inositol phospholipids and therefore a knockout would be expected to also have a 
more stable pool of PtIns(4,5)P2. If it is the depletion o f phospholipids which is 
responsible for lithium action then this would also lead to resistance but in a mppA- 
independent manner. Therefore these mutants allow us to investigate the mechanism 
of lithium action on chemotaxis and genetically test the inositol depletion hypothesis
116
to understand more about the role of inositol signaling and recycling in cell 
movement.
5.2 Generation of PLC knockout strains
Previously it has been shown that the Dictyostelium  genome contains a single pic 
gene, of the delta family, and that disruption of this is sufficient to stop all 
Ins(l,4,5)P3 production from PtIns(4,5)P2 (Drayer et al., 1994). Although it was 
reported that this mutation had no effect on chemotaxis when compared to a random 
integrant, when this mutant was compared with our laboratory wild-type strain it was 
found to move significantly faster (Fig. 5.1). In addition, the published pic  knockout 
was made in the Ax3 genetic background whereas our laboratory uses the Ax2 wild- 
type strain and therefore it was necessary to generate a new knockout in order to make 
comparisons with our existing mutants.
As previously, a knockout construct was made consisting of two homologous regions 
separated by the FLOX-flanked blasticidin cassette and therefore inside the cell, a 
homologous recombination event would lead to both insertion o f the blasticidin 
cassette and a deletion o f ~100bp of coding sequence from the middle of the PLC 
locus, inactivating the gene (Fig. 5.2). Our laboratory wild-type cells were therefore 
transformed with this construct and clones screened by PCR of the genomic PLC 
locus. After this screen, positive clones were tested for the presence of PLC protein 
by western blot using an antibody raised to the N-terminus of the Dictyostelium 
protein (a gift from P. van Haastert) (Drayer et al., 1994); in all cases,
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Figure 5.1: The published PLC null cells are not comparable to our laboratory strains. The
wild-type strain from our laboratory (Ax2) and the published Ax3-background PLC null cell line 
(HD 10) were analysed in the random movement assay described previously. The results are 
representative o f two independent experiments.
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Figure 5.2: Generation of a new PLC knockout. (A) Schematic of knockout construct design. (B) 
Confirmation of recombination by PCR from genomic DNA using the primers indicated above, positive 
KO clones give a product which is 1.3 Kb larger due to the insertion o f the blasticidin cassette. Clones 
where the construct integrated elsewhere produce a product o f 1.8Kb. (C) Western blot of extracts from 
knockout clones probed with a specific a-PLC antibody. HD 10 is the published mutant and HD11 is the 
published random integrant control.
119
A2 0 0
180
160  -
Wild-type pic- mppA- mppA-/plc-
B
120
Wild-type PLC- MlPPa-
Figure 5.3: MIPP and PO activity in pic  null cells. (A) The particulate fractions from cell extracts 
were incubated with InsP6 and activity measured as the rate o f Ins(l,4,5)P3 production/minute. 
Results are calculated relative to wild-type cells and are the mean ± standard deviation of three 
independent experiments. (B) PO activity in the soluble fraction o f mutant cell extracts was 
measured relative to wild-type.
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no protein was detectable and we conclude that the cells are indeed knockouts (Fig. 
5.2).
In the original mutant, the most obvious phenotype seen was an increase in 
lns(l ,3,4.5.6)P? hydrolysis. When MIPP activity was measured in our mutants a 50 ± 
25 % increase in activity was seen, confirming this observation (Fig. 5.3). When PO 
activity was measured in these cells, no change was seen indicating that in this case, 
MippA is regulated by an alternative mechanism.
5.3 Generating mppA'/plc' double mutants
As cre-recombinase treated mppA knockout cells were previously isolated, it was 
possible to transform these with the PLC knockout construct and generate mppA'Iplc 
double mutants. When these cells were screened as above, homologous recombination 
occurred as predicted and again, no PLC protein could be detected in positive clones 
by western blot (Fig. 5.2). In addition, when double mutant cell extracts were 
prepared, no MIPP activity was found, indicating that there was again no 
compensatory up-regulation of mppB in these cells (Fig. 5.3) and therefore these 
double mutants are unable to generate Ins(l,4,5)P3 from either PtIns(4,5)P2 or InsP6.
It is interesting that although both known pathways o f Ins(l,4,5)P3 synthesis are 
disrupted, these cells have no obvious growth defect and are still able to undergo 
development and form normal fruiting bodies (Fig. 5.4). In fact, when Ins(l,4,5)P3 
was measured in these cells, it was not significantly different from either wild-type, or
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the mppA' parent (Fig. 5.5), indicating that a third, alternative route of synthesis must 
exist.
It in the absence o f PLC and MIPP activity, Ins(l,4,5)P3 levels are maintained by the 
upregulation of a third pathway, we might expect to see changes in the levels of the 
inositol polyphosphates. However when quantified by HPLC, again no significant 
differences were seen between the mutants, although this may again be due to the 
limitations of this technique as previously discussed (Table 5.1)
5.4 The secretion of inositol phosphates in mppA and pic null cells
In the course o f measuring the Ins(l,4,5)P3 content o f cells, it became apparent that it 
was also rapidly accumulating in the medium such that when placed in fresh medium, 
after 5 hours the amount o f Ins(l,4,5)P3 in the medium is as much as 10 fold the 
amount inside the cells, accumulating at 4 pmol/min/107 cells (Fig. 5.6). 
Unfortunately due to the large volumes of media required to extract sufficient 
secreted inositol polyphosphates we were unable to use our HPLC system and 
therefore cannot tell if  other inositol polyphosphates are also released. Consequently 
we do not know whether it is released as Ins(l,4,5)P3 or secreted in a different form 
and formed by extracellular kinases or phosphatases. This phenomenon has been 
previously reported in Dictyostelium  and it was estimated that as much as 10% of the 
intracellular Ins(l,4,5)P3 is released per minute (Van Haastert, 1989).
If Ins( 1.4,5)P3 is actively secreted, it may give an indication of the rate of turnover 
within the cell as, in order to maintain intracellular levels, both synthesis and
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Figure 5.4: The development of mppA  and pic  null cells. Cells were plated clonally on SM 
agar plates with a lawn o f bacteria. Images were taken from the centre of the plaques which 
were formed after one week.
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Figure 5.5: Ins(l,4,5)P3 levels in m ppA/plc  double knockout cells. Inositol phosphates were extracted 
from vegetative cells grown in the absence o f exogenous inositol and Ins(l,4,5)P3 levels quantified using 
the isotope dilution assay. Values plotted are the means ± standard deviation o f three independent 
determinations.
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Pmol ' 107 cells
\ \ ' i  U -type p ic ' mppA '/plc'
InsP3 0 0 0
Ins( 1235/1246)1%* 1 1 0
Ins(l  3 4 6 /1 2 3 4 ) P f 24 10 16
Ins(1245)P4* 0 0 0
ln s (1 3 4 5 )P 4 0 0 0
In s ( 1 2 5 6 ) P f 60 42 56
Ins(2456)P4’ 12 29 24
Ins( 14 5 6 )P 4 0 0 0
Ins(12346)Ps 20 15 17
ln s (1 2 3 4 5 ) lV 1 0 0
In s ( 1 2 4 5 6 ) P f 192 181 186
In s (1 3 4 5 6 )P s 52 46 54
InsP6 527 575 719
InsP7’ * 65 53 56
InsPg** 33 47 48
Total 1009 1057 1292
Table 5.1: Inositol phosphate abundance in pic  and mppA  null cells. Cell extracts 
were prepared and analysed by HPLC to quantify inositol phosphate abundance. 
Where indicated, isomers could not be separated. Inositol phosphates marked * are 
not commercially available and therefore a standard curve was estimated from other 
similar isomers. Compounds marked ** are also unavailable but also have no 
available isomers. Therefore in these cases a standard curve was estimated from InsP6 
values corrected for phosphate content. All values are the mean o f at least 3 
independent determinations.
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import/export would have to remain balanced. When the rate of Ins(l,4,5)P3 secretion 
was measured in pic  and mppA' mutants it was found to be reduced by -50%  in both 
cases, indicating that extracellular Ins(l,4,5)P3 is not produced exclusively by either 
enzyme (Fig. 5.6). In mppA’/plc double mutants however the rate of Ins(l,4,5)P3 
accumulation was reduced even further, to 40% of wild-type demonstrating that 
although intracellular levels o f Ins(l,4,5)P3 do not hugely change, these mutants have 
significant differences in inositol polyphosphate turnover resulting in a decreased rate 
of extracellular accumulation.
5.5 pic and mppA’/plc cells are lithium resistant
Although disruption o f the single Dictyostelium pic  gene has been reported to have no 
effect on chemotaxis, our previous experiments would predict that the changes in 
inositol metabolism that occur in this mutant might lead to altered lithium sensitivity. 
When pic  cells were treated with 7mM lithium chloride and placed in a gradient of 
chemoattractant. movement was not significantly inhibited, compared with wild-type 
where speed was reduced to 77% (Fig. 5.7) and therefore pic  cells are lithium 
resistant (P=0.03).
To determine whether this resistance is due to elevated MippA activity and therefore 
by a similar mechanism as clpoA null cells, the assay was repeated with the mppA'/plc 
double mutant. Again, these cells were more resistant than wild-type, and speed was 
only moderately reduced to 87% (P<0.05). This data would however suggest that in 
pic cells, lithium resistance is independent of MippA and therefore is likely to be due 
to altered lipid, rather than soluble inositide metabolism and signalling.
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5.6 ipmal and ino 1 expression is not regulated by PLC
Although lithium resistance in pic  cells appears to be MippA-independent, the 
mechanism o f resistance may still be due to changes in gene expression. However, 
when the levels o f ipm al and inol expression were quantified in pic  cells, they were 
not significantly changed relative to wild-type, despite increased MippA activity (Fig. 
5.8). This therefore demonstrates that pic  cells are resistant to the effects of lithium 
by a different mechanism than dpoA' cells, independent o f a simple up-regulation of 
its target IMPase family genes.
5.7 Discussion
5.7.1 Pathways of Ins(l,4 ,5)P 3 synthesis
In order to make a reasonable comparison with existing mutant strains from our 
laboratory, new PLC null cells were generated. As previously reported, these mutants 
again have no obvious growth or developmental defects and maintain normal levels of 
Ins( 1,4.5)P3 levels due to up-regulation of MippA. As all known pathways of 
Ins( 1,4,5)P3 synthesis require the activity of either PLC or MIPP it was a surprise to 
find that in mppA'/plc double mutants, when both of these pathways are disrupted, 
significant amounts o f Ins(l,4,5)P3 remain. As these cells have no detectable InsP6 
phosphatase activity, Ins(l,4,5)P3 must therefore be due produced by either another 
phospholipase, or a novel route -  possibly by the phosphorylation of inositol.
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Figure 5.6: The extracellular accumulation of Ins(l,4,5)P3. (A) Wild-type cells were placed in 
fresh m ediur . and grown in shaking suspension. At the times shown, samples were removed, the 
cells removed by centrifugation, and the amount o f  Ins(l,4,5)P3 in the medium measured by the 
isotope dilution assay. The results o f  a typical experiment are shown. (B) The rate o f extracellular 
lns(l,4,5)P3 accum ulation in mppA and pic  null cells was measured relative to wild-type. Values 
plotted represent the mean ± standard deviation o f at least two independent experiments.
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Figure 5.7: The lithium sensitivity of p ic  mutant strains. The effect o f 7mM LiCl on chemotaxing 
mutant cells was m easured as previously using a chemotaxis chamber. Both speed and chemotactic 
index were norm alised to control values obtained in 7mM NaCl on the same day. Results plotted are 
the means ± standard deviation o f four independent experiments. * P<0.05, Student’s T-test.
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Figure 5.8: E xpression levels o f in o l  and  im p a l in pic  cells. Expression, relative to wild-type 
cells was measured by Q-RT PCR. Results are the mean ± standard error o f three independent 
experiments.
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Although we do not fully understand the physiological role of Ins(l,4,5)P3 in 
Dictyostelium , the fact that disruption o f two of its synthetic pathways does not affect 
movement indicates that it does not play a significant role as a second messenger for 
chemotaxis. Studies in a mammalian tissue culture model, using a truncated cytosolic 
MIPP construct have however shown that the basal Ins(l,4,5)P3 levels can affect basal 
calcium levels, which therefore may explain why Ins(l,4,5)P3 is so robustly 
maintained in Dictyostelium  (Yu et al., 2003).
5.7.2 Extracellular Ins(l,4 ,5)P3 accumulation
Although I do not detect any changes in inositol polyphosphate abundance between 
any of these mutants, the rate o f Ins(l,4,5)P3 accumulation outside o f the cell is 
significantly changed. Why cells secrete such large amounts o f inositol 
polyphosphates is an interesting question. As the rate o f extracellular accumulation is 
so significant, it is unlikely to simply be due to cell leakage, and as inositol 
polyphosphates are highly charged molecules they are unlikely to be able to cross 
membranes passively. Unfortunately, as analysis by HPLC was not possible it is 
unclear whether Ins(l,4,5)P3 is itself secreted, or is released in another form and 
converted by an extracellular enzyme but the fact that this accumulation is reduced 
but still present in both mppA and pic  null cells suggests that this is not the case and 
that it is connected to the rate at which Ins(l,4,5)p3 can be synthesized internally. In 
the experiments described here, we have effectively removed all the extracellular 
inositol phosphates at the start and therefore whether these cells will continue to 
accumulate extracellular inositol phosphates or reach an equilibrium is unknown; if an 
equilibrium is reached, the level o f this may be related to the intracellular levels of
Ins(1.4.5)P3 and therefore may ultimately be unchanged in both PLC and MIPP null 
cells when growing normally.
Althought inositol phosphatate secretion is relatively unknown, it does not appear be 
restricted to Dictyostelium. The presence o f extracellular Ins(l,4,5)P3 was first 
identified in the interstitial fluid o f the rat hippocampus and was shown to be 
increased upon activation o f the muscarinic receptor by pharmacological agonists, 
reflecting changes in the intracellular levels (Minisclou et al., 1994). This report was 
subsequently confirmed by a study in both cortical brain slices and a human 
neuroblastoma cell line, showing that InsP 2 and InsP4  were also exported - although 
they did not look for InsP 5 or InsP6 (Roberts et al., 1997). In both these studies 
however, an increase in extracellular inositol phosphate levels was only seen after 
stimulation o f the internal levels, indicating that the rate o f export was directly linked 
to the intracellular metabolism. This would agree with these observations in 
Dictyostelium  where it appears that the rate of extracellular accumulation is also 
related to the rate o f inositol phosphate turnover.
Why cells might do this is unclear - in mammalian cells the amount exported only 
represented about 2-4% o f the amount induced by agonist stimulation so it is unlikely 
that its purpose is to attenuate the signal (Roberts et al., 1997). An alternative 
explanation might be that extracellular inositides are involved in intercellular 
signaling. However, as these Dictyostelium  mutants have reduced export but no 
obvious developmental defect this may not be the case, unless the extracellular levels 
reach a stable equilibrium concentration which is unchanged in these cells. What is 
clear however, is that these extracellular inositides represent a significant pool and the
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rate of accumulation appears to be representative of the rate of intracellular synthesis, 
and not simply the basal level o f Ins(l,4,5)P3.
5.7.3 The effects of lithium on chemotaxis, and resistance in pic cells
This study has shown that, although they have no chemotactic phenotype under 
normal conditions, pic ' cells are resistant to the effects of lithium. In addition, this 
resistance is independent o f MippA activity and is not accompanied by an increase in 
IMPase expression indicating an alternative mechanism of resistance that is based 
upon metabolic changes.
When cells are treated with lithium, the levels of wyo-inositol are reduced which has 
been shown to lead to a reduced rate o f inositol lipid biosynthesis and Ptlns levels in 
several organisms (Ciapa and Maggio, 1993; Ding and Greenberg, 2003; Joseph et al., 
1987). This also produces a reduction in the basal levels of Ins(l,4,5)P3 and therefore 
both phospholipid, and Ins(l,4,5)P3 signalling may be affected. As PLC represents the 
sole link between inositol phospholipid and soluble inositide signaling manipulation 
of this gene allows us to genetically separate the two and the observation that mppA' 
/pic' double mutants remain resistant to lithium shows that the PLC null mutation is 
genetically epistatic and therefore it is a disruption of lipid hydrolysis, and not soluble 
inositide metabolism that is crucial for the determination of lithium sensitivity.
This data implies that by inhibiting the recycling of inositol, lithium is able to deplete 
the levels o f inositol phospholipids and block movement. In cells lacking PLC 
activity, the pool o f inositol phospholipids cannot be depleted by hydrolysis and is
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therefore more stable and less sensitive to lithium. This model would also predict that, 
although increased MIPP activity may help, this resistance is largely independent of 
higher inositol phosphate metabolism and Ins(l,4,5)P3 production as indeed was 
observed.
5.7.4 A role of PLC in chemotaxis?
If mutation o f PLC is able to confer lithium resistance by stabilization of the pool of 
phospholipids, the regulation o f this pool may be part of its physiological role.
Indeed. PLC may play a more significant role by the removal of PtIns(4,5)P2 than by 
the formation o f Ins(l,4,5)P3. As the recycling of Ins(l,4,5)P3 back to Ptlns requires 
the action o f multiple enzymes as well as transport between compartments, this will 
be a relatively slow process and therefore, although it may not play a role in direct 
signalling, PLC activity may act as a general attenuator of inositol lipid signaling.
As PLC activity has been shown to decrease thoughout early development this may 
also partly explain the increase in both inositol lipids and cell polarity which are 
observed at the same time (Cubitt and Firtel, 1992; Ellingson, 1974). Although similar 
effects are not observed in a PLC knockout it should be noted that in these cells, both 
the rate of PtIns(4.5)P2 synthesis and the total amount o f PtIns(4,5)P2 are unchanged 
(Drayer et al., 1994). For this to be the case there must be an up-regulation of an 
alternative pathway for the removal o f inositol phospholipids from the membrane, 
which would suppress inositol lipid accumulation . Indeed, functional redundancy 
would seem to be a common property of inositol metabolism in general, and the data
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presented throughout this study all indicates the importance of the rate of inositide 
turnov er, in both the action of lithium and of chemotaxis in general.
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Chapter 6: 
Discussion
6.1 The aims of this work
The main aim o f this study is to clarify and understand the effects of lithium on cell 
movement and chemotaxis. Previous work in this laboratory has identified a mutation 
of the dpoA gene which confers lithium resistance and also has altered inositol 
metabolism. It has previously been suggested that the theraputic action of lithium is 
by inhibition o f inositol signaling (Berridge et al., 1989) and therefore an aim of this 
project was to determine whether it is these changes in inositol metabolism that are 
responsible for lithium resistance in this mutant. In addition, by determining the 
mechanism o f lithium resistance in this and other inositol metabolic mutants, I hope 
to understand both the mechanism o f lithium action, and the role o f inositol 
metabolism in cell motility.
6.2 Lithium as a tool for studying cell movement
In this work I have shown that lithium is able to inhibit cell movement in a dose- 
dependant manner, explaining how lithium treatment is able to block Dictyostelium  
aggregation and development. Furthermore, as this inhibition is seen in both 
chemotaxing and randomly moving cells, the action of lithium is not to block 
chemotactic signal transduction, but to inhibit the underlying fundamental cell 
movement. This is a very robust system, indicative of its fundamental role, and none 
of the mutants generated in this study have any significant movement or 
developmental phenotype unless the overall level of inositol is lowered by lithium 
treatment. As these mutants are affected to a different extent by lithium this allows us
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to gain insight into the role of the affected genes and signaling pathways, providing a 
usetul tool for the study o f this basic motility and cell behaviour.
6.3 The mechanism of lithium resistance in dpoA' cells
Previous work has shown that in dpoA null cells, lithium resistance is accompanied by 
an increase in the rate o f Ins(l,4,5)P3 production from InsP6. I have identified and 
cloned the Dictyostelium  homologue o f MIPP, the enzyme responsible for this 
activity and shown that it is required for lithium resistance in dpoA null cells. This 
demonstrates that resistance is due to the altered metabolism o f the higher order 
inositol phosphates. Although an increase in MIPP activity and Ins(l,4,5)P3 synthesis 
may be able to overcome some o f the inositol-depleting effects of lithium, cells 
expressing very high levels o f MippA actually become hypersensitive and therefore 
the changes in lithium sensitivity must be due to a different mechanism.
In cells treated with a PO-specific inhibitor, the expression of all three IMPase-family 
genes as well as ino l were up-regulated in a MippA dependant manner. Therefore, in 
this case, lithium sensitivity is likely to determined by transcription, where increased 
RNA (and therefore presumably protein) levels of IMPase and IPP1 and 2 coincide 
with lithium resistance, and decreased expression of IMPase reflects the lithium 
hypersensitivity observed in mppA overexpressing cells. Work in our laboratory has 
previousl) demonstrated that overexpression of IMPase is sufficient to give lithium 
resistance (Keim-Reder, 2006) and therefore, if  these changes in RNA levels are 
representative o f protein levels, when prolyl oligopeptidase activity is disrupted, cells 
become more resistant to lithium due to a MIPP-mediated increase in IMPase and IPP
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levels providing strong evidence that it is indeed the inhibition of these enzymes that 
is responsible for inhibition o f cell movement.
Although we know little about the physiological role of PO, this represents a novel 
signaling pathway where PO is able to act as a master regulator of inositol 
metabolism through the control o f gene expression. Although we do not know how 
MIPP activity is regulated, other than it does not seem to be at a transcriptional level 
or even any of the biological substrates o f PO, the fact that MIPP activity is modified 
in both PO and in PLC-null cells (independent of PO) implies that it may have a 
signaling role and this may be important in a number o f processes. The challenge now 
is therefore to understand how this happens and to determine the physiological role of 
both MIPP and PO.
6.4 Inositol phosphate metabolism and transcriptional regulation
This study shows that MIPP activity is required for the transcriptional regulation of 
inol and im pal by PO. As overexpression of two independent nuclear inositol kinases 
also produces a similar change in expression, it appears that the same pathway is 
involved and that the level o f transcription is related to the inositide status of the cell. 
As it is specifically only the genes directly involved in the production of myo-inositol, 
and not higher order inositol metabolism that are regulated, the purpose of this 
regulation is likely to be the maintenance of phospholipid levels comparable to that 
extensively studied in yeast. The regulation of these genes is also complex, as in pic 
cells the expression o f both inol or impal is unchanged, despite having a comparable 
increase in MIPP activity to dpoA null cells. This, and the observation in mppA
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overexpressing cells that im pal expression is down-regulated independently of inol, 
indicates that there are multiple pathways involved and that the actual level of 
expression is due to the integration o f a number of signals.
In yeast, inol expression can be regulated by a number o f different processes, using 
numerous sensors o f inositide status, including inositol itself as well as the higher 
order inositol phosphates, via chromatin remodeling (Hirsch and Henry, 1986; Kelley 
et al., 1988; Loewen et al., 2004; Shen et al., 2003; Steger et al., 2003). In addition, 
the UAS ino containing genes, including inol, are negatively regulated by the O pilp 
transcriptional regulator which itself can be regulated by a number o f mechanisms 
including phosphorylation by protein kinases A and C and retention in the ER by 
binding to phosphatidic acid and vesicle-associated-membrane-protein-associated 
protein (VAP) (Loewen et al., 2004; Loewen et al., 2003; Sreenivas and Carman, 
2003; Sreenivas et al.. 2001). As some o f these factors are able to regulate the level of 
expression independantly, the ultimate read-out o f RNA levels is an integration of 
several signals. This therefore may explain the unchanged expression of inol in PLC 
null cells, as even if elevated MIPP activity affects chromatin remodeling to facilitate 
transcription, other changes in the lipid metabolism may lead to repression through 
factors such as O pilp , canceling this out. Indeed, this would also make metabolic 
sense, as if a pathway o f phospholipid hydrolysis is blocked, a cell is unlikely to try 
and upregulate inositol lipid synthesis.
The transcriptional regulation of im pal is considerably less well understood. In yeast, 
expression o f 7MA7, the gene encoding IMPase, is increased by growth in inositol and 
decreased by inositol starvation although the mechanism is unknown (Murray and
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Greenberg. 1997; Murray and Greenberg, 2000). In addition IMN1 is also down- 
regulated by lithium and VPA treatment, probably due to decreased inositol levels.
1 herelore as up-regulation of inol will lead to increased inositol availability, it is 
likely that im pal expression is regulated as a direct consequence.
Although these experiments show that higher inositol phosphate metabolism is able to 
regulate gene expression, it is impossible to say from this study which of these 
mechanisms are involved. However, these observations in Dictyostelium  do fit with 
the more detailed transcriptional studies in yeast so it appears that at least some of 
these regulatory pathways are conserved. Whatever pathways are involved, these 
experiments demonstrate that the higher order inositol phosphate metabolism can 
affect the transcription o f lithium-sensitive genes, and alter the ability of the cell to 
tolerate treatment which may have implications for the understanding of both lithium 
treatment, and bipolar disorder.
6.5 Inositol phosphate m etabolism and chemotaxis
Much of the research into the role o f inositol signaling in chemotaxis has concentrated 
on the activation o f PI-3’ kinase and PTEN, leading to the localized production of 
PtIns(3,4,5)P3 and the recruitment o f PH-domain containing proteins to the leading 
edge (1 laugh et al., 2000; Parent et al., 1998; Servant et al., 2000). Although a recent 
study has questioned whether this itself is responsible for directional sensing, or 
provides a supplementary increase in local actin polymerization, the production and 
regulation o f PtIn(3,4,5)P3 clearly plays an important role, and is crucial for normal 
aggregation (Loovers et al., 2006). In contrast, both Ins(l,4,5)P3 and calcium
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signaling appear to be dispensible, as cells lacking either pic  and iplA activity are still 
able to chemotax normally (Draver et al., 1994; Traynor et al., 2000). In this study I 
have shown that lithium treatment is able to block cell movement due to inhibition of 
IMPase and IPP and therefore although Ins(l,4,5)P3 may not be a signal, the recycling 
ol inositol phosphates is clearly important for maintaining cell movement.
If the production o f inositol lipids is important for chemotaxis, as PLC is able to 
remove them it may also play an important role. Although the concentration of 
PtIns(4,5)P2 is too high to itself be used as a signal by cAMP-activated PLC, PLC 
activity may act as a general attenuator of inositol lipid signaling, regulating the 
turnover o f the lipid pool by removing the inositol head group and forcing it to 
undergo a slow multi-step recycling process. As the rate o f PtIns(4,5)P2 synthesis 
remains constant in pic  null cells (Drayer et al., 1994) there are clearly other routes by 
which inositol lipids are lost, but as the action of IMPase is essential for both 
recycling and de novo synthesis, lithium allows us to effectively block both pathways. 
As this leads to inhibition o f cell movement, the efficient replenishment of the 
dynamic lipid pool plays an important role in the maintenance o f motility.
6.6 Summary
In this study, I have shown that lithium is able to block aggregation due to inhibition 
of the IMPase family o f genes. Inhibition of IMPase and IP reduces both the recycling 
and de novo synthesis o f inositol lipids and it is therefore this process that is crucial 
for basic cell movement. In addition, I have demonstrated that this process is subject 
to regulation by PO, via the metabolism of the higher inositol phosphates, with
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implications both in basic cell biology, and for the understanding and treatment of 
bipolar disorder.
The metabolism and signaling o f the inositol polyphosphates and lipids, represents an 
enormously complex system, which due to this complexity, is often studied at the 
individual enzyme level. In this study however, most of the enzymes involved do not 
themselves produce an important second messenger signal and therefore it is more 
appropriate to think in terms o f metabolic flow. Indeed, in soluble inositol phosphate 
metabolism, such as the production o f Ins(l,4,5)P3, there appears to be a significant 
amount o f redundancy indicating that in this case, it is the flow, rather than the 
specific pathway which is important. Therefore, metabolic flow is responsible for 
maintaining cell movement, and it is by the inhibition o f this that lithium exerts its 
effects on cell movement.
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Appendix I:
Design and Validation of Quantitative 
Real-Time PCR Assays
A l.l  Design of Primers
For each gene o f interest, specific primers were designed to produce a product of 
approximately 100-200bp and to have a melting temperature of approximately 57°C 
(see Table Al . l ) .  As an internal loading control primers were also designed for the 
lg7 gene encoding the mitochondrial large subunit rRNA which should remain 
constant. To accurately check that each primer set generated a single, clean product 
cDNA synthesized from wild-type cells was used as the template in real-time PCR 
reactions using the Sybr green fluorescent dye, which fluoresces upon binding double­
stranded DNA. After the reactions had completed 35 cycles, the reaction products 
were analysed by slowly increasing the temperature so that as the melting point o f 
each product is reached, it will dissociate leading to a drop in fluorescence. As 
different products will have different melting temperatures, multiple products or 
primer dimers can easily be identified. This is mostly clearly seen by plotting the rate 
o f change in fluorescence against temperature such that the dissociation of a product 
is seen as a peak.
When the primer sets were tested in this way, using cDNA from vegetative wild-type 
cells as template, a single peak was observed in each case indicating a good, discrete 
product suitable for qualitative analysis (Fig. Al . l ) .  Control reactions, with no 
template present gave no significant signal, with the exception of the inol and ipkAl 
primer sets where a peak was seen at a lower temperature, indicating primer dimers. 
These however are not a problem in the presence of template due to the preferential 
formation of the true product.
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Gene Orientation Sequence Melting
Temperature
(°c)
Product
Size
(bp)
inol Forward GACACCGTCGTCGTTATGTGGTCCG 67.9 437
Reverse GC A ATC AT AT CAT CG AC AAC ATTT G 58.1
impal Forward GGT A AT G AACC AAC AT GGGT A ATT G 59.7 465
Reverse GCT GT ACCT GAG A AT CTT AAT GCTT G A AC 63.9
ippA Forward AG AGG A AC AAT GT G AA AT ACC AAC 57.6 421
Reverse TT G AACTTT AT C ATT G AAAT G AG AGGC 58.9
ippB Forward GAT C A AG AGG A AC C A ATT A AGGTTT C 60.1 323
Reverse C CTTTT G AGT AAT CT A ATT GTT GTTT 55.3
mppA Forward ACC A AT G AA AT AC A A ACC AC A AT CC 58.1 124
Reverse TCCATCCACTCCCAATGAACC 59.8
ipkB Forward TTACAGTTGGCTACTACTTGTCAGATTCC 63.9 198
Reverse ATGGATTATCAAGGTCACCTAACTCATCA 62.4
ipkAl Forward GCAGGTTCAACACCATTCAAAAAATC 60.1 176
Reverse TCCAACACTATCCATTCCTTACCATC 61.6
ipkA2 Forward T GGT AGTTTTTT G AGT GT C AGCCC 61.0 174
Reverse T GAT GAT GTT GTT GTT GTT GTT GT AGT G 60.7
ig7 long Forward GTACTTAAACCGCTGGTTAATTG 57.1 343
Reverse CGCTACCTTAGGACCGTCATAGTTAC 64.8
ig7 short Forward TCCAAGAGGAAGAGGAGAACTGC 62.4 137
Reverse TGGGGAG\GTCGTTACACCATTC 62.1
Table A l.l:  Real -  time PCR primer details
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Figure A l.l:  Melting curve analysis of real time PCR products. Typical examples o f the melting curves 
for each primer set used. The rate o f change in fluorescence is plotted and therefore peaks indicate a large 
change in fluorescence due by the dissociation of any double stranded products formed. Control reactions 
with no cDNA template are also plotted
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A 1.2 Verification of a logarithmic response to template concentration
In order to be accurately used quantitatively, each primer set must behave in a linear 
manner to varying template concentration. To verify this, plasmid DNA containing 
cloned sequence for either mppA, or ipkA, B or C was used as template for each 
respective set o f primers. Note that the ig7, inol, impal, ippA and ippB primers were 
validated previously by others in this laboratory (Keim-Reder, 2006). By using a 
known concentration o f template, the change c(T) value with template copy number 
could be plotted (Fig. A l .2). As expected, each primer set showed a linear 
relationship and therefore can be used for quantitative measurments.
A 1.3 Comparison of primer efficiency with the internal control
As the 2'aac( 1 ] method was to be used to calculate the relative expression of each gene 
normalized to an internal loading control it is important that each target gene has a 
similar amplification efficiency to the loading control (Livak and Schmittgen, 2001). 
PCR efficiencies can be compared by by performing a titration o f cDNA template and 
measuring the c(T) values measured for each gene and the control. If the efficiency is 
similar for both genes, the difference between the two c(T) values at each dilution will 
remain constant. This was seen to be largely the case for all the primer sets (Fig.
Al .3). Although the mppA and ipkB reactions do seem to give a slight upwards 
gradient, over the range o f change in expression levels observed in this study this 
would prove insignificant. This therefore indicates a single product and comparable
efficiency for each primer set and validation that they may be used for quantiation 
using the 2'AAC(I) method (Livak and Schmittgen, 2001).
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Figure A1.2: c(T) value has a linear response to increasing template. Plasmid DNA of known 
concentration containing each gene was used as template for real-time PCR reactions to verify a linear 
relationship between copy number and c(T) value. Reactions were all done in triplicate.
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Figure A1.3: Comparison of PCR efficiencies. To compare amplification efficiency of the product for 
each gene with the Ig7 internal control a cDNA serial dilution was analysed by real-time PCR. Each 
dilution was tested with each set o f gene specific primers as well as the Ig7 loading control in triplicate. 
The values plotted are the difference between the c(T) values of the gene-specific primer and Ig7 at each 
cDNA dilution: therefore a horizontal line indicates an equal response to template dilution for both sets 
of primers.
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Appendix II: 
Unprocessed chemotaxis data
Speed (p m /m in )
Exp erim en t
1 2 3 4 Mean ±
Wild-type NaCl 9 .7 8 8 .5 0 7 .95 10 .90 9 .28 0 .66
LiCI 8 .0 0 5 .6 8 6 .4 0 8 .5 2 7 .15 0 .67
LSI 0 .8 2 0 .6 7 0.81 0 .7 8 0 .77 0 .07
dpoA' NaCl 8 .0 9 8 .4 5 10 .03 8 .3 6 8 .73 0 .44
LiCI 8 .5 7 7 .0 7 8 .22 8 .2 0 8 .02 0.33
LSI 1 .06 0 .8 4 0 .8 2 0 .9 8 0 .92 0.12
m ppA NaCl
LiCI
LSI
8 .0 2
6 .4 6
0 .8 1
8 .3 4
6 .6 7
0 .8 0
8 .8 9
5 .81
0 .65
8 .42
6 .31
0 .75
0 .25
0 .26
0.09
m ppA /dpoA NaCl 9 .8 3 9 .2 3 10 .35 1 1 .12 10.13 0 .40
LiCI 6 .6 8 7 .1 2 6 .8 6 7 .96 7.16 0 .28
LSI 0 .6 8 0 .7 7 0 .6 6 0 .7 2 0.71 0 .05
mppA o/e NaCl 8 .4 8 8 .61 7 .23 7 .4 8 7.95 0 .35
LiCI 4 .4 1 5 .9 0 3 .74 4 .2 8 4 .58 0 .46
LSI 0 .5 2 0 .6 9 0 .5 2 0 .5 7 0 .57 0 .08
pic NaCl 9 .8 2 8 .0 2 9 .5 9 7 .8 0 8.81 0 .52
LiCI 7 .9 0 1 0 .69 8 .3 5 1 0 .22 9 .29 0 .69
LSI 0 .8 0 1 .00 0 .8 7 1 .00 0 .92 0 .10
mppA'/plc NaCl 8 .0 2 9 .1 3 1 1 .57 1 2 .83 10 .39 1.10
LiCI 6 .5 7 8 .6 8 1 0 .27 10 .31 8 .96 0 .88
LSI 0 .8 2 0 .9 5 0 .8 9 0 .8 0 0 .87 0 .07
D irectionality
E xp erim en t
1 2 3 4 Mean ±
Wild-type NaCl 0 .8 1 0 .6 9 0 .6 7 0 .7 2 0 .72 0 .03
LiCI 0 .6 8 0 .5 4 0 .63 0 .6 2 0 .62 0 .03
LSI 0 .8 4 0 .7 8 0 .9 4 0 .8 6 0 .86 0 .07
dpoA NaCl 0 .6 5 0 .6 8 0 .6 9 0 .6 6 0 .67 0.01
LiCI 0 .6 0 0 .6 7 0 .6 4 0 .6 9 0 .65 0 .02
LSI 0 .9 2 0 .9 9 0 .9 3 1 .05 0 .97 0 .06
m ppA NaCl 0 .6 8 0 .71 0 .7 0 0.70 0 .01
LiCI 0 .5 6 0 .5 3 0 .4 3 0 .51 0 .04
LSI 0 .8 2 0 .7 5 0 .61 0 .73 0.11
m ppA/dpoA ' NaCl 0 .7 0 0 .7 0 0 .7 6 0 .71 0 .72 0.01
LiCI 0 .5 9 0 .5 0 0 .55 0 .4 8 0 .53 0 .02
LSI 0 .8 4 0 .71 0 .7 2 0 .6 8 0 .7 4 0 .07
mppA o/e NaCl 0 .6 6 0 .71 0 .53 0 .6 8 0 .65 0 .04
LiCI 0 .3 8 0 .4 8 0 .2 8 0 .4 8 0 .41 0 .05
LSI 0 .5 8 0 .6 8 0 .53 0 .71 0 .62 0 .08
pic' NaCl 0 .6 7 0 .6 9 0 .6 8 0 .6 8 0 .68 0 .00
LiCI 0 .6 3 0 .6 8 0 .6 0 0 .7 2 0 .66 0 .03
LSI 0 .9 4 0 .9 9 0 .8 8 1 .06 0.97 0 .07
mppA'/plc' NaCl 0 .6 1 0 .71 0 .64 0 .5 8 0 .64 0 .03
LiCI 0 .5 3 0 .61 0 .75 0 .6 5 0 .64 0 .05
LSI 0 .8 7 0 .8 6 1 .17 1 .12 1.01 0 .16
Table A2.2: Raw DIAS data for chemotaxing cells. Speed and chemotactic index was 
measured in a number o f independent experiments for each mutant. Values shown are the 
mean for each independent experiment. LSI indicates the ratio of the LiCL to the NaCl value 
on each day. Errors represent the standard error for absolute speed and C.I., and standard 
deviation for LSI.
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Appendix III:
Gene, Protein and Strain Nomenclature
Nomenclature for Dictyostelium  proteins used in this work
Gene name Protein Name Activity/notes Dictybase ref.
m ppA Multiple Inositol 
Polyphosphate Phosphatase A  
(M ippA)
InsP6 2 7 3 7 6 ’ phosphatase / 
phytase
D D B 0 1 86447
m p p B MippB N ot expressed in vegetative  
o f  developing cells
D D B 0 2 18876
ipkA I Inositol Polyphosphate Kinase  
( I p k A l)
In s ( l ,4 ,5 )P 3 3 7 6 ’ kinase D D B 0 2 0 3 6 1 4
ipkA2 IpkA2 A s above D D B 0 2 18526
ipkA 3 IpkA3 Lacks conserved proline  
residue o f  IpkAl and A2
D D B 0 2 0 4 6 3 9
ipkB IpkB Ins(l ,3 ,4 )P3 5 7 6 ’ kinase / 
Ins(3,4,5 ,6)P4 r  kinase
D D B 0190521
ipkC IpkC I n s ( l ,3 ,4 ,5 ,6 )P5 2 ’ kinase D D B O 187902
i m p a l Inositol M onoPhosphatase  
(IM Pase)
InsP phosphatase D D B 0 2 0 4 1 0 0
ippA Inositol Polyphosphate  
Phosphatase (IppA)
InsP2 phosphatase DDBO 167248
ippB IppB InsP2 1 ’ phosphatase / PAP  
phosphatase?
D D B 0 1 89923
p i c  p i p  A PhosphoLipase C (PLC) Delta class inositide-specific  
PtIns(4,5)P2 lipase
D D B 0 2 0 1 6 5 6
dpoA Prolyl Oligopeptidase  A 
(D p o A )
Cleaves peptides after 
proline residues
DDBO 185041
p is  A Phosphatidyl Inositol Synthase  
(P isA)
Generates Ptlns from m y o­
inositol and C D P -D A G
D D B 0 2 18645
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Strain  nom enclature
S train  Name P aren t G enotype Notes
HAD230 Ax2 mppA' /  Bsrr Clone 1
HAD231 Ax2 m ppA'/ Bsr Clone 2
HAD234 HAD230 mpp' /  Bsrs Cre-lox treated mppA KO
HAD236 Ax2 pic /  Bsr Clone 1
HAD237 Ax2 p ic '/  Bsr Clone 2
HAD243 HAD234 m ppA'/ p ic /  Bsr Clone 1
HAD244 HAD234 m ppA'/ p ic /  Bsr Clone 2
HAD246 HAD234 m ppA'/ dpoA'/ Bsr Clone 1
HAD247 HAD234 mppA'/  dpoA'/  Bsr Clone 2
HD 10 Ax3 p ic  /  G418' Published pic  KO 
(Drayer et al., 1994)
HD11 Ax3 p lc v,/G 4 1 8 r Published p ic  random 
integrant
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